Track market-moving stories before they get noisy

Aurora Investment Counsel bought a new stake in Diamondback Energy, Inc. (NASDAQ:FANG – Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 7,478 shares of the oil and natural gas company’s stock, valued at approximately $1,314,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Laurel Wealth Advisors LLC bought a new stake in shares of Diamondback Energy during the 4th quarter worth about $26,000. Cedar Mountain Advisors LLC bought a new stake in Diamondback Energy during the first quarter worth approximately $26,000. JPL Wealth Management LLC bought a new stake in Diamondback Energy during the third quarter worth approximately $26,000. Wellington Shields & Co. LLC raised its holdings in Diamondback Energy by 264.7% during the fourth quarter. Wellington Shields & Co. LLC now owns 186 shares of the oil and natural gas company’s stock worth $28,000 after purchasing an additional 135 shares in the last quarter. Finally, Meeder Asset Management Inc. acquired a new stake in Diamondback Energy in the second quarter worth approximately $28,000. Institutional investors own 90.01% of the company’s stock.

Insider Transactions at Diamondback Energy In related news, Director Charles Alvin Meloy sold 33,333 shares of the stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $198.41, for a total value of $6,613,600.53. Following the transaction, the director owned 818,197 shares in the company, valued at approximately $162,338,466.77. This represents a 3.91% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Matt Zmigrosky sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $200.54, for a total transaction of $1,002,700.00. Following the transaction, the executive vice president directly owned 46,392 shares in the company, valued at approximately $9,303,451.68. The trade was a 9.73% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 129,167 shares of company stock valued at $24,714,309 over the last 90 days. Company insiders own 0.64% of the company’s stock.

Analysts Set New Price Targets A number of equities analysts have issued reports on the company. Mizuho increased their price target on Diamondback Energy from $220.00 to $240.00 and gave the company an “outperform” rating in a research note on Wednesday, May 27th. Raymond James Financial restated a “strong-buy” rating and issued a $248.00 price objective on shares of Diamondback Energy in a report on Friday, July 31st. Susquehanna raised their target price on Diamondback Energy from $245.00 to $255.00 and gave the company a “positive” rating in a research note on Tuesday, July 21st. Weiss Ratings raised Diamondback Energy from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 31st. Finally, Roth Capital set a $212.00 target price on Diamondback Energy and gave the stock a “buy” rating in a report on Monday, June 22nd. Four equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $222.21. View Our Latest Research Report on Diamondback Energy

Key Stories Impacting Diamondback Energy Here are the key news stories impacting Diamondback Energy this week:

Positive Sentiment: Morgan Stanley reaffirmed its Equal Weight rating but raised or maintained a $216 price target, implying modest upside from the referenced price. The target provides some support, though the neutral rating limits the bullish signal. Morgan Stanley rating report Positive Sentiment: Zacks Research increased its FY2028 EPS forecast to $15.37 from $14.83, suggesting potential longer-term earnings improvement. Diamondback Energy valuation and pipeline venture article Neutral Sentiment: Analysts continue to rate FANG Hold or Equal Weight, indicating neither a strong bullish nor bearish consensus. Diamondback’s Permian-to-Katy gas pipeline strategy and participation in the Solitude Pipeline venture could broaden its midstream exposure, but the investment benefits remain dependent on execution and future cash flows. Diamondback Permian-to-Katy gas pipeline article Negative Sentiment: Zacks Research cut several near- and medium-term forecasts: Q3 2026 EPS to $2.70 from $4.32, Q4 2026 to $3.11 from $4.19, FY2026 to $16.52 from $18.11, FY2027 to $14.95 from $16.42, Q4 2027 to $3.08 from $3.87, and Q1 2028 to $3.12 from $3.57. Additional reductions affected Q2 and Q3 2027 estimates. These revisions outweigh the isolated FY2028 increase and are likely pressuring the stock. Diamondback Energy Stock Down 0.7% FANG stock opened at $208.55 on Thursday. The company has a 50 day moving average of $191.03 and a two-hundred day moving average of $188.74. The company has a market cap of $58.40 billion, a price-to-earnings ratio of 40.65 and a beta of 0.43. Diamondback Energy, Inc. has a 12-month low of $134.30 and a 12-month high of $214.51. The company has a quick ratio of 0.45, a current ratio of 0.47 and a debt-to-equity ratio of 0.25.

Diamondback Energy (NASDAQ:FANG – Get Free Report) last posted its quarterly earnings results on Monday, August 3rd. The oil and natural gas company reported $6.48 EPS for the quarter, beating the consensus estimate of $6.08 by $0.40. Diamondback Energy had a net margin of 8.58% and a return on equity of 10.10%. The business had revenue of $5.56 billion for the quarter, compared to analysts’ expectations of $4.89 billion. During the same period in the previous year, the company posted $2.38 EPS. Diamondback Energy’s revenue was up 51.2% on a year-over-year basis. On average, equities analysts anticipate that Diamondback Energy, Inc. will post 19.3 earnings per share for the current fiscal year.

Diamondback Energy Announces Dividend The company also recently announced a quarterly dividend, which will be paid on Thursday, August 20th. Shareholders of record on Thursday, August 13th will be given a $1.10 dividend. This represents a $4.40 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend is Thursday, August 13th. Diamondback Energy’s dividend payout ratio is presently 85.77%.

(Free Report)

Diamondback Energy, Inc (NASDAQ: FANG) is an independent oil and natural gas company focused on the development, exploration and production of unconventional resources in the Permian Basin. Headquartered in Midland, Texas, the company concentrates its operations in the core Midland and Delaware sub‑basins of West Texas and southeastern New Mexico, where it pursues contiguous acreage positions to support repeatable drilling programs.

Diamondback’s activities span the upstream value chain, including leasehold acquisition, well planning, drilling, completion and production optimization.

See Also Five stocks we like better than Diamondback Energy Bloom Energy’s AI Surge Meets a Valuation Reality Check Target Is Winning Shoppers Back—Can the Rally Reach $180? IonQ’s Space Contract Points to a New Frontier for Quantum Investors Is Apple’s AI Strategy Smarter Than Skeptics Think? Want to see what other hedge funds are holding FANG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Diamondback Energy, Inc. (NASDAQ:FANG – Free Report).

Receive News & Ratings for Diamondback Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diamondback Energy and related companies with MarketBeat.com's FREE daily email newsletter.

Dutch Bros (BROS +3.78%) has been remarkably consistent in a tough consumer spending environment, but its premium price tag creates volatility.

On Aug. 5, the Oregon-based coffee chain reported strong second-quarter results, including 8.3% same-store sales growth for company-owned stores. Loyal Dutch Rewards customers continue to drive results, with the rewards program now accounting for 74% of transactions.

Yet Dutch Bros stock fell 18% the next day and recently was down about 22%, despite beating expectations and raising guidance for the year. A reaction like that typically says more about the stock's valuation than the health of the business.

Image source: The Motley Fool.

Loyal customers drive consistent results The company was lapping a challenging comparison after increasing same-store sales by 7.8% in Q2 2025. Building on those results, company-owned stores grew roughly 16% on a two-year stacked basis.

This was the company's 13th consecutive quarter of positive same-store sales and its eighth straight quarter of transaction growth. That traffic, up 3.4% this quarter, makes Dutch Bros stand out in a restaurant industry where many chains are struggling with declining visits.

The drive-thru specialist continues to benefit from rising demand for convenient, customized caffeinated beverages. Starbucks launched its blended energy refreshers last month to compete for that same afternoon crowd.

Is the valuation still stretched? Before earnings, the stock traded at around 66 times forward earnings estimates. After the drop, the multiple compressed to a more reasonable, but still premium, 46 times. Conservative guidance for third-quarter same-store sales of 4% to 5%, a step down from recent results, may have contributed to the sell-off.

Today's Change

(

3.78

%) $

1.83

Current Price

$

50.27

Higher costs continued this quarter, as expected, weighing on profit margins. Food costs rose to 26.1% of company-operated revenue, up 80 basis points year over year, driven by higher coffee costs and the rollout of its new food offerings. Occupancy costs also climbed 50 basis points as the company shifted toward build-to-suit leases.

Despite rising costs, earnings are still expected to grow by 70% in fiscal 2026 to $0.92 per share.

The simplicity of the drive-thru model is part of the appeal, but the addressable market is what makes the investment case compelling. The cold beverage chain has 1,225 shops today and management says it could reach 3,500 locations just by expanding in its current markets.

Management's aspirational goal is to reach up to 7,000 domestic shops, offering investors a rare long-term growth story in the restaurant industry. The recent pullback provides an opportunity to add shares, though the stock's still not cheap, warranting a disciplined approach.

BlackRock Inc. bought a new stake in F5, Inc. (NASDAQ:FFIV – Free Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 6,278,577 shares of the network technology company’s stock, valued at approximately $2,611,637,000. BlackRock Inc. owned 11.13% of F5 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of FFIV. Persistent Asset Partners Ltd acquired a new position in shares of F5 in the 2nd quarter valued at $36,000. Hazlett Burt & Watson Inc. acquired a new stake in shares of F5 during the 4th quarter worth $26,000. Hantz Financial Services Inc. grew its position in F5 by 109.8% during the fourth quarter. Hantz Financial Services Inc. now owns 107 shares of the network technology company’s stock valued at $27,000 after acquiring an additional 56 shares during the period. Elyxium Wealth LLC purchased a new stake in F5 during the fourth quarter valued at about $28,000. Finally, SJS Investment Consulting Inc. increased its stake in F5 by 963.6% during the first quarter. SJS Investment Consulting Inc. now owns 117 shares of the network technology company’s stock worth $34,000 after acquiring an additional 106 shares during the last quarter. Institutional investors and hedge funds own 90.66% of the company’s stock.

F5 Price Performance Shares of FFIV opened at $382.63 on Thursday. F5, Inc. has a 12 month low of $223.76 and a 12 month high of $435.00. The stock’s 50-day moving average is $404.38 and its two-hundred day moving average is $346.88. The stock has a market cap of $21.67 billion, a PE ratio of 30.46, a P/E/G ratio of 3.85 and a beta of 1.03.

F5 (NASDAQ:FFIV – Get Free Report) last announced its earnings results on Monday, July 27th. The network technology company reported $4.73 EPS for the quarter, beating the consensus estimate of $4.00 by $0.73. The business had revenue of $865.08 million for the quarter, compared to the consensus estimate of $834.60 million. F5 had a return on equity of 21.54% and a net margin of 21.95%.The company’s revenue was up 10.9% on a year-over-year basis. During the same period last year, the business posted $4.16 EPS. F5 has set its Q4 2026 guidance at 4.140-4.260 EPS and its FY 2026 guidance at 17.210-17.330 EPS. On average, research analysts anticipate that F5, Inc. will post 13.65 earnings per share for the current year. Insider Activity at F5 In related news, CTO Kunal Anand sold 392 shares of F5 stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $404.63, for a total value of $158,614.96. Following the completion of the sale, the chief technology officer owned 12,586 shares in the company, valued at approximately $5,092,673.18. The trade was a 3.02% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider John Anthony Maddison sold 1,000 shares of the company’s stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $405.85, for a total transaction of $405,850.00. Following the completion of the sale, the insider owned 1,353 shares in the company, valued at approximately $549,115.05. This trade represents a 42.50% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 15,699 shares of company stock valued at $6,316,411. 0.48% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In A number of equities analysts have recently commented on the company. Zacks Research downgraded F5 from a “strong-buy” rating to a “hold” rating in a report on Monday, July 27th. Needham & Company LLC reissued a “hold” rating on shares of F5 in a research report on Tuesday, July 28th. Morgan Stanley raised their price target on shares of F5 from $380.00 to $415.00 and gave the company an “equal weight” rating in a report on Tuesday, July 28th. Piper Sandler reaffirmed an “overweight” rating and set a $461.00 price target (up from $423.00) on shares of F5 in a research report on Tuesday, July 28th. Finally, Barclays boosted their price objective on shares of F5 from $386.00 to $397.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 28th. Five investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, F5 currently has a consensus rating of “Hold” and a consensus target price of $416.62.

Get Our Latest Research Report on FFIV

F5 Profile (Free Report)

F5 Inc (NASDAQ:FFIV) specializes in application services and delivery networking, helping organizations ensure the availability, performance and security of their applications. The company’s core offerings include advanced load balancing, traffic management and application security solutions designed to optimize user experiences and protect against threats such as distributed denial-of-service (DDoS) attacks and web application exploits.

At the heart of F5’s product portfolio is the BIG-IP platform, which provides a suite of software modules for local and global traffic management, secure web application firewalling and DNS service delivery.

Featured Stories Five stocks we like better than F5 Bloom Energy’s AI Surge Meets a Valuation Reality Check Target Is Winning Shoppers Back—Can the Rally Reach $180? IonQ’s Space Contract Points to a New Frontier for Quantum Investors Is Apple’s AI Strategy Smarter Than Skeptics Think?

Receive News & Ratings for F5 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for F5 and related companies with MarketBeat.com's FREE daily email newsletter.

BlackRock Inc. bought a new position in Onto Innovation Inc. (NYSE:ONTO – Free Report) in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 5,505,181 shares of the semiconductor company’s stock, valued at approximately $2,083,436,000. BlackRock Inc. owned 11.07% of Onto Innovation at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in ONTO. Pallas Capital Advisors LLC bought a new stake in shares of Onto Innovation in the second quarter valued at about $562,000. Deutsche Bank AG bought a new position in Onto Innovation during the 2nd quarter worth about $4,124,000. Perigon Wealth Management LLC bought a new position in Onto Innovation during the 2nd quarter worth about $285,000. TimesSquare Capital Management LLC purchased a new position in Onto Innovation during the 2nd quarter valued at about $82,166,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in Onto Innovation during the 2nd quarter valued at about $42,000. Institutional investors own 98.35% of the company’s stock.

Onto Innovation Stock Performance ONTO stock opened at $299.30 on Thursday. Onto Innovation Inc. has a one year low of $101.00 and a one year high of $386.46. The firm has a market cap of $14.69 billion, a price-to-earnings ratio of 112.52, a PEG ratio of 1.05 and a beta of 1.59. The company has a debt-to-equity ratio of 0.77, a quick ratio of 8.33 and a current ratio of 9.73. The firm has a 50-day simple moving average of $305.60 and a two-hundred day simple moving average of $262.54.

Onto Innovation (NYSE:ONTO – Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The semiconductor company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.69 by $0.24. Onto Innovation had a net margin of 11.84% and a return on equity of 13.44%. The firm had revenue of $343.13 million for the quarter, compared to the consensus estimate of $325.29 million. During the same quarter in the previous year, the firm earned $1.25 EPS. The company’s quarterly revenue was up 35.3% compared to the same quarter last year. Onto Innovation has set its Q3 2026 guidance at 2.180-2.380 EPS. On average, equities analysts forecast that Onto Innovation Inc. will post 7.88 EPS for the current fiscal year. Wall Street Analyst Weigh In Several equities research analysts have recently weighed in on ONTO shares. B. Riley Financial reaffirmed a “buy” rating on shares of Onto Innovation in a research report on Friday, August 7th. Weiss Ratings lowered shares of Onto Innovation from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, August 7th. Freedom Capital upgraded Onto Innovation to a “strong-buy” rating in a report on Wednesday, June 17th. The Goldman Sachs Group initiated coverage on Onto Innovation in a research report on Monday. They set a “buy” rating and a $400.00 target price on the stock. Finally, Needham & Company LLC lifted their price target on Onto Innovation from $330.00 to $360.00 and gave the company a “buy” rating in a report on Friday, August 7th. Two research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $380.30.

Read Our Latest Stock Analysis on ONTO

(Free Report)

Onto Innovation (NYSE:ONTO) is a global supplier of advanced process control and inspection systems for semiconductor and electronics manufacturers. The company’s solutions span metrology, inspection, defect review and lithography mask repair, helping customers optimize yield, reduce costs and improve device performance. By integrating high-resolution optical and e-beam tools with sophisticated software analytics, Onto Innovation enables wafer, mask and advanced packaging producers to maintain tight process control across leading-edge nodes and specialty applications.

Key products include high-throughput wafer metrology systems, optical and e-beam defect inspection platforms, mask inspection and repair tools, and data-driven software for yield management and process optimization.

Further Reading Five stocks we like better than Onto Innovation Bloom Energy’s AI Surge Meets a Valuation Reality Check Target Is Winning Shoppers Back—Can the Rally Reach $180? IonQ’s Space Contract Points to a New Frontier for Quantum Investors Is Apple’s AI Strategy Smarter Than Skeptics Think?

Receive News & Ratings for Onto Innovation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Onto Innovation and related companies with MarketBeat.com's FREE daily email newsletter.

VANCOUVER, BC / ACCESS Newswire / August 20, 2026 / (TSXV:OGN)(OTCQX:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce it has acquired a 2% Net Smelter Return ("NSR") royalty (the "Royalty") on the Haldane silver project in Yukon Territory, Canada.

Haldane Royalty Highlights1,2,3,4

Haldane is a high-grade silver project owned by Silver North Resources Ltd. ("Silver North") (TSXV:SNAG)

The Royalty is uncapped with no buy-downs and covers 86 square kilometres on the extension of the Keno Hill silver district and namesake mine, operated by Hecla Mining Company (Figures 1,2)

Four Keno-style vein targets confirmed to date at Haldane with significant potential for new blind discoveries

Haldane has been progressively explored and drilled since 2019 including drill holes HLD25-31 grading 818 grams per tonne ("g/t") silver, 1.39 g/t gold, 2.54% lead, and 0.98% zinc over 13.15 metres and HLD21-24 intersecting 1,351 g/t silver, 2.43% lead, and 2.91% zinc over 5.2 metres

Drilling at Haldane is under way with up to 14,000 metres planned for 2026 and 2027

"Keno Hill is one of the highest-grade silver districts in the world with over 35 historical mine sites producing approximately 217 million ounces of silver. The Haldane royalty acquisition was based on the strong geological potential of the project backed by solid operatorship at Silver North, and we are excited to be part of this emerging silver discovery," said Paddy Nicol, CEO of Orogen. "Silver North is a well financed and technically driven company with sufficient funding to explore Haldane over 2026 and 2027. We look forward to exploration results as they materialize."

Figure 1: Location of the Haldane project

About the Haldane Project

Keno Hill produced approximately 217 million ounces of silver from 1913 to 1989 with an average grade of 1,149 g/t silver, 5.62% lead and 3.14% zinc. The Keno Hill district is currently held by Hecla Mining Company who produced over 3.0 million ounces of silver, 3.63 kilotons of lead and 2.24 kilotons of zinc in 2025. 2,3

The Haldane project covers the western extension of the Keno Hill Quartzite formation, the host of the best developed mineralization in the Keno Hill district (Figure 2). The project is centered on a series of mineralized veins within a structural corridor that has historically produced small-scale high-grade silver at the Middlecoff zone and Johnson vein.

To date, four Keno-style vein targets have been identified at Haldane. The Main Zone Fault is the most advanced target on the property with the first successful drill testing in 2024 intersecting a wide zone of Keno style silver bearing veins, vein breccia and stockwork mineralization. Follow up drilling in 2025 extended mineralization to 100 metres of strike and 150 metres down dip with highlight drill hole HLD25-31 grading 818 g/t silver, 1.39 g/t gold, 2.64% lead and 0.98% zinc over 13.15 metres from 249.9 metres down hole and included 3.2 metres at 2,014 g/t silver.4

The property contains significant potential for new vein discoveries with only 37 drill holes prior to the current exploration campaign testing less than 10% of the mapped vein strike on the property. Silver North are currently conducting a two year, two rig drill program up to 14,000 metres, focused on expansion of the Main zone and testing new silver targets. Approximately 2,550 metres of drilling in ten holes have been completed at the Main Fault structure with assays pending.5

Acquisition Terms

Under the terms of the Haldane Royalty Acquisition Agreement (the "Agreement") Orogen have agreed to the following payment schedule to the vendors of the 2% NSR royalty:

C$500,000 on closing the Agreement (paid);

30% of future royalty revenue capped at C$1.5 million ("First Future Payment"); and

15% of future royalty revenue capped at C$1 million to be paid after the completion of the First Future Payment

Figure 2: Simplified Regional Geology of the Keno Hill District from Silver North2

Qualified Person Statement

All technical disclosure in this release is a summary of previously released information, and the Company is relying on the interpretation provided by the relevant company. Additional information can be found on the links in the footnotes or on SEDAR+ (www.sedarplus.ca).

All new technical data, as disclosed in this press release, has been reviewed and approved by Laurence Pryer, Ph.D., P.Geo., VP Exploration for Orogen. Dr. Pryer is a qualified person as defined under the terms of National Instrument 43-101.

About Orogen Royalties Inc.

Orogen Royalties is focused on organic royalty creation and royalty acquisitions on precious and base metal discoveries in western North America. The Company's royalty portfolio includes the Ermitaño gold and silver Mine in Sonora, Mexico (2.0% NSR royalty) operated by First Majestic Silver Corp. The Company is well financed with several projects actively being developed by exploration partners.

On Behalf of the Board

OROGEN ROYALTIES INC.

Paddy Nicol
President & CEO

To find out more about Orogen, please contact Paddy Nicol, President & CEO at 604-248-8648, and Marco LoCascio, Vice President of Corporate Development at 604-248-8648. Visit our website at www.orogenroyalties.com.

Orogen Royalties Inc.
1015 - 789 West Pender Street
Vancouver, BC
Canada V6C 1H2

https://silvernorthres.com/silver-north-outlines-largest-exploration-program-to-date-at-haldane-following-2025-success/

https://silvernorthres.com/presentations/

https://www.hecla.com/operations/hecla-keno-hill-yukon-territory-canada

https://silvernorthres.com/project/haldane/

https://silvernorthres.com/silver-north-continues-haldane-drilling-and-commences-veronica-exploration-yukon/

https://wp-banyangold-2026.tor1.cdn.digitaloceanspaces.com/media/2025/08/BANAUR08E_NI-43-101-Technical-Report-2026.06.26.pdf

Forward Looking Information

This news release includes certain statements that may be deemed "forward looking statements". All statements in this presentation, other than statements of historical facts, that address events or developments that Orogen Royalties Inc. (the "Company") expect to occur, are forward looking statements. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur.

Although the Company believe the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Factors that could cause the actual results to differ materially from those in forward looking statements include market prices, exploitation and exploration successes, and continued availability of capital and financing, and general economic, market or business conditions.

Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward looking statements. Forward looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. Except as required by securities laws, the Company undertakes no obligation to update these forward looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Orogen Royalties Inc

Hot Line Presentation of Primary Results from ACACIA-HCM to Elaborate on Positive Topline Results in Patients with Non-Obstructive Hypertrophic Cardiomyopathy

Company to Host In-Person and Virtual Investor Event to Discuss Results from
Late-Breaking Science Presentations

SOUTH SAN FRANCISCO, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced upcoming presentations, including a Hot Line presentation and two Late Breaking Science presentations, at the European Society of Cardiology (ESC) Congress, taking place August 28-31 in Munich, Germany.

Hot Line and Late-Breaking Science Presentations

Title: ACACIA-HCM: Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
Presenter: Ahmad Masri, M.D., M.S., Associate Professor of Medicine, Director of the Hypertrophic Cardiomyopathy Center at Oregon Health & Science University
Date: Friday, August 28, 2026
Session Title: Hot Line 1
Session Time: 11:00 AM – 12:18 PM CEST
Presentation Time: 11:45 – 11:58 AM CEST
Location: Munich, Main Auditorium (Hall B3)

Title: Effect of Aficamten on Cardiac Structure and Function in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy - Results from the ACACIA-HCM Trial
Presenter: Sheila Hegde, M.D., MPH, Assistant Professor, University of Texas Southwestern Medical Center – Dallas, TX and Affiliate Faculty, Brigham and Women's Hospital, Boston, MA
Date: Saturday, August 29, 2026
Session Title: Late-Breaking Clinical Science: Hypertrophic Cardiomyopathy
Session Time: 4:15 – 5:15 PM CEST
Presentation Time: 4:15 – 4:30 PM CEST
Location: Ashgabat (Hall A3)

Title: Aficamten vs. Metoprolol Monotherapy in Obstructive Hypertrophic Cardiomyopathy According to Pre-Trial Treatment in MAPLE-HCM
Presenter: Fernando Dominguez, M.D., Ph.D., Consultant Cardiologist, Hospital Universitario Puerta De Hierro Majadahonda – Madrid, Spain
Date: Saturday, August 29, 2026
Session Title: Late-Breaking Clinical Science: Hypertrophic Cardiomyopathy
Session Time: 4:15 – 5:15 PM CEST
Presentation Time: 4:30 – 4:45 PM CEST
Location: Ashgabat (Hall A3)

Poster Presentations

Title: Impact of Peak Provoked Left Ventricular Outflow Tract Gradients on Health-Related Quality of Life in Patients With Hypertrophic Cardiomyopathy: A Real-World Cross-Sectional Survey
Presenter: Paulos Gebrehiwet, Ph.D., M.S., Senior Manager, Health Economics and Outcomes Research Europe, Cytokinetics
Session Date: Saturday, August 29, 2026
Session Title: Improving Diagnosis and Treatment in Hypertrophic Cardiomyopathy
Session Time: 8:15 AM – 9:00 AM CEST
Location: Station 12 (Research Gateway – Hall A1)

Title: Real-World Clinical Burden of Obstructive Hypertrophic Cardiomyopathy: A Nationwide Study in France
Presenter: Prof. Albert Hagege, M.D., Ph.D., Director, Cardiovascular Department, European Hospital Georges Pompidou, Paris, France
Session Title: Hypertrophic Cardiomyopathy: Disease Burden, Risk Stratification, and Clinical Outcomes
Session Date: Sunday, August 30, 2026
Session Time: 12:15 PM – 1:00 PM CEST
Location: Exchange Circle 3 (Research Gateway – Hall A1)

Investor Event and Webcast

Cytokinetics will host an in-person investor event in Munich, Germany on August 28, 2026 at 2:00 PM Central European Summer Time (8:00 AM Eastern Time). The event will also be simultaneously webcast live online. Interested parties must register to attend in-person or online at https://acacia-hcm-investor-event-esc-2026.open-exchange.net/registration.

Registered attendees may access the webcast by visiting the Investor & Media section of the Cytokinetics website at www.cytokinetics.com. The webcast replay will be archived on the Cytokinetics website for six months.

About Cytokinetics

Cytokinetics is a specialty cardiovascular biopharmaceutical company, building on its over 25 years of pioneering scientific innovations in muscle biology, and advancing a pipeline of potential new medicines for patients suffering from diseases of cardiac muscle dysfunction. Cytokinetics’ MYQORZO® (aficamten) is a cardiac myosin inhibitor approved in the U.S., China, EU and UK for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Following positive topline results in ACACIA-HCM, a Phase 3 clinical trial of aficamten in patients with non-obstructive HCM (nHCM), the company plans to discuss the results with the U.S. FDA and other regulatory authorities. Cytokinetics is also developing omecamtiv mecarbil, an investigational cardiac myosin activator for the potential treatment of patients with heart failure with severely reduced ejection fraction and ulacamten, an investigational cardiac myosin inhibitor for the potential treatment of heart failure with preserved ejection fraction, while continuing pre-clinical research and development in muscle biology.

For additional information about Cytokinetics, visit www.cytokinetics.com and follow us on X, LinkedIn, Facebook and YouTube.

Forward-Looking Statements

This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the “Act”). Cytokinetics disclaims any intent or obligation to update these forward-looking statements and claims the protection of the Act’s Safe Harbor for forward-looking statements. Examples of such statements include, but are not limited to, statements relating to the enrollment, expected results or timing of completion of any of our clinical trials, the clinical meaningfulness, persuasiveness or interpretation of clinical trial results, including for purposes of regulatory approval, labeling, or market acceptance, the results of long-term, secondary or exploratory analyses, including analyses of time to first cardiovascular event, statements relating to our ability to obtain regulatory approval for aficamten in nonobstructive hypertrophic cardiomyopathy in any jurisdiction by any particular date, if ever, the number of patients comprising the eligible treatment population for aficamten, or market acceptance of aficamten for the treatment of nonobstructive hypertrophic cardiomyopathy. Such statements are based on management’s current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to, potential difficulties or delays in the development, testing, regulatory approvals for trial commencement, progression or product sale or manufacturing of Cytokinetics’ drug candidates that could slow or prevent clinical development or product approval; Cytokinetics’ drug candidates may have adverse side effects or inadequate therapeutic efficacy; the FDA or foreign regulatory agencies may delay or limit Cytokinetics’ ability to conduct clinical trials; Cytokinetics may be unable to obtain or maintain patent or trade secret protection for its intellectual property; standards of care may change, rendering Cytokinetics’ drug candidates obsolete; and competitive products or alternative therapies may be developed by others for the treatment of indications Cytokinetics’ drug candidates and potential drug candidates may target. For further information regarding these and other risks related to Cytokinetics’ business, investors should consult Cytokinetics’ filings with the Securities and Exchange Commission including the risk factors included in Cytokinetics’ most recent Annual Report on Form 10-K and subsequent reports filed with the SEC.

CYTOKINETICS® and the CYTOKINETICS C-shaped logo are registered trademarks of Cytokinetics in the U.S. and certain other countries.

MYQORZO® is a registered trademark of Cytokinetics in the U.S. and the European Union.

Contact:
Cytokinetics
Diane Weiser
Senior Vice President, Corporate Affairs
(415) 290-7757

Energetická společnost Photon Energy zveřejnila výsledky hospodaření za 2Q a první polovinu roku 2026. Ve druhém čtvrtletí společnosti meziročně vzrostly výnosy a provozní zisk EBITDA se více než zdvojnásobil. Čistá ztráta se meziročně snížila.

Výsledky společnosti Photon Energy (BAAPEN) za 2Q 2026   2Q 2026 2Q 2025 Výnosy (mil. EUR) 28,38 25,71 Zisk EBITDA (mil. EUR) 5,77 2,84 Zisk EBIT (mil. EUR) 3,04 -0,50 Výsledky za 2Q 2026 Výnosy ve druhém čtvrtletí meziročně vzrostly o 10,4 % na 28,38 mil. EUR. Výnosy z prodeje elektřiny se zvýšily o 20,5 % na 9,82 mil. EUR, k čemuž přispěla vyšší výroba elektřiny a vyšší realizované ceny.

Ostatní výnosy vzrostly o 5,7 % na 18,56 mil. EUR. Výnosy ze segmentu obchodování s technologiemi vzrostly o 55,8 % na 9,79 mil. EUR, zatímco v segmentu Engineering klesly z 5,25 mil. EUR na 0,26 mil. EUR.

Zisk EBITDA dosáhl 5,77 mil. EUR oproti 2,84 mil. EUR ve stejném období minulého roku. Podle společnosti k růstu přispělo zlepšení provozních fundamentů, důsledná nákladová disciplína a pokračující přínosy programu optimalizace nákladů. Osobní náklady meziročně klesly o 27,7 % a ostatní provozní náklady o 47,6 %.

Zisk EBIT dosáhl 3,04 mil. EUR, zatímco ve 2Q 2025 společnost vykázala provozní ztrátu 0,50 mil. EUR.

Vývoj výnosů, provozního zisku EBITDA a EBITDA marže, zdroj: Photon EnergyČistá ztráta se meziročně snížila z 3,26 mil. EUR na 0,36 mil. EUR.

Provozní hotovostní toky dosáhly ve 2Q 5,92 mil. EUR (2Q 2025: 8,20 mil. EUR).

Výroba elektřiny dosáhla 55,1 GWh, meziročně o 10,0 % více, k čemuž podle společnosti přispěly příznivé povětrnostní podmínky. Celkem 14,6 MWp provozních aktiv přitom zůstávalo částečně odstaveno kvůli probíhajícímu licenčnímu procesu. V červenci získala licenci elektrárna Săhăteni o výkonu 7,1 MWp, zatímco u zbývajících 7,6 MWp projektu Făget 3 společnost očekává získání licence ve 4Q. Průměrná realizovaná cena vzrostla ze 169 EUR/MWh na 177 EUR/MWh.

Výsledky za 1H 2026 Za první polovinu roku výnosy meziročně klesly o 4,8 % na 45,46 mil. EUR. EBITDA naopak vzrostla o 48,1 % na 5,99 mil. EUR a EBIT dosáhl 1,10 mil. EUR oproti ztrátě 1,28 mil. EUR v 1H 2025. Čistá ztráta činila 4,95 mil. EUR oproti 6,96 mil. EUR v předchozím roce. Výroba elektřiny za první pololetí vzrostla o 4,7 % na 77,2 GWh.

Vývoj ve společnosti Photon Energy nadále pokračuje v restrukturalizaci skupiny, přičemž podle managementu podnikání nadále ovlivňují omezení v oblasti likvidity. Společnost pokračuje také v monetizaci vybraných aktiv. V Rumunsku probíhá prodej projektových práv o výkonu 41,7 MWp a provozních aktiv o výkonu 4,9 MWp.

Společnost rovněž připravuje restrukturalizaci zeleného dluhopisu EUR Green Bond 2021/2027. Přípravná opatření mají být předložena držitelům dluhopisů k hlasování bez fyzické schůze v období od 1. do 8. září 2026.

Akcie Photon Energy Akcie společnosti Photon Energy (BAAPEN) na pražské burze posilují o 0,29 % na 6,94 Kč.

Zdroj: Photon Energy

Marek Krejčiřík, Fio banka, a.s.

NASHVILLE, Tenn., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced positive results from a prospective, randomized, contralateral-eye study evaluating IHEEZO® (chloroprocaine hydrochloride ophthalmic gel) 3%, an ophthalmic gel indicated for ocular surface anesthesia, in patients undergoing same-day bilateral intravitreal injections. The single-center, investigator-initiated study demonstrated statistically significant differences favoring IHEEZO at every measured time point.

Patients reported approximately 58% less discomfort overall in the IHEEZO-treated eye than in the fellow eye treated with proparacaine ophthalmic solution 0.5%, a statistically significant difference at all four post-injection assessments (all p≤0.048). The largest absolute treatment differences were observed immediately after injection, when discomfort is highest: 1.44 versus 3.06 at two minutes and 1.26 versus 2.82 at one hour, while lower discomfort scores with IHEEZO remained evident through the 24-hour assessment.

Millionsi of intravitreal injections are performed in the United States each year — making them among the most frequently performed procedures in ophthalmology — and they are often administered repeatedly over months or years to patients with retinal diseases. As a result, the injection experience, including patient discomfort, can become an important consideration for both patients and retina specialists, particularly in practices managing a high volume of patients who return regularly for treatment.

Study Results

IHEEZO was associated with lower patient-reported discomfort at all four post-injection assessments, measured using a standard 0-to-10 numeric rating scale:

The results showed a consistent benefit with IHEEZO throughout the 24-hour assessment period, with lower patient-reported discomfort at every time point. The largest absolute differences occurred shortly after injection, when discomfort is highest. Absolute treatment differences were 1.62 points at two minutes and 1.56 points at one hour, and lower discomfort scores with IHEEZO remained evident through the 24-hour assessment.

“Patient comfort is a larger part of the intravitreal injection experience than it is sometimes given credit for,” said Travis Peck, MD, Retina Consultants of Delmarva, principal investigator of the study. “Because each patient received both anesthetic approaches on the same day, we were able to directly compare the patient experience. Patients consistently reported less discomfort in the IHEEZO-treated eye across all time points we measured. For retina specialists who perform a high volume of injections and care for patients who return repeatedly for treatment, these are practical and clinically relevant findings.”

“These results provide new clinical evidence from a real-world practice setting supporting IHEEZO’s differentiated clinical profile versus commonly administered legacy ophthalmic anesthesia modalities – demonstrating a measurable improvement in patient-reported comfort following intravitreal injections,” said Mark L. Baum, Chief Executive Officer of Harrow. “Retina specialists work to preserve vision in patients who require ongoing treatment over many years, and the experience of each of those visits matters and ideally, should be optimized. The consistency and magnitude of the reduction in patient discomfort should strengthen physician confidence in IHEEZO’s clinical profile and support broader utilization of the product across retina practices.”

About the Study

The investigator-initiated study was a prospective, randomized, contralateral-eye comparison conducted in a private retina practice. The study evaluated 100 eyes from 50 adult patients undergoing same-day bilateral intravitreal injections. Both eyes received 2% lidocaine-soaked pledgets prior to administration of the randomized study anesthetic. In each patient, one randomly assigned eye received IHEEZO prior to injection and the fellow eye received preservative-containing proparacaine ophthalmic solution 0.5%, allowing each patient to serve as his or her own control and reducing between-patient variability.

Patient-reported ocular discomfort was assessed using a 0-to-10 numeric rating scale at 2 minutes, 1 hour, 6–12 hours, and 24 hours following injection.

IHEEZO® (chloroprocaine hydrochloride ophthalmic gel) 3%, for topical ophthalmic use

INDICATIONS AND USAGE

IHEEZO is an ester anesthetic indicated for ocular surface anesthesia.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

IHEEZO is contraindicated in patients with a history of hypersensitivity to any component of this preparation

WARNINGS AND PRECAUTIONS

Not for Injection or Intraocular AdministrationCorneal Injury Due to InsensitivityCorneal OpacificationFor Administration by Healthcare Provider: IHEEZO is not intended for patient self-administration ADVERSE REACTIONS

Most common adverse reaction is mydriasis (approximately 25%)
Please see full Prescribing information 

About Harrow

Harrow, Inc. (Nasdaq: HROW) is a leading provider of ophthalmic disease management solutions in North America, offering a comprehensive portfolio of products that address conditions affecting both the front and back of the eye, such as dry eye disease, wet (or neovascular) age-related macular degeneration, cataracts, refractive errors, glaucoma and a range of other ocular surface conditions and diseases of the retina. Harrow was founded with a commitment to deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes. For more information about Harrow, please visit harrow.com and connect with us on LinkedIn.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered such “forward-looking statements.” Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties which may cause results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from those predicted include, among others, risks related to: liquidity or results of operations; our ability to successfully implement our business plan, develop and commercialize our products, product candidates and proprietary formulations in a timely manner or at all, identify and acquire additional products, manage our pharmacy operations, service our debt, obtain financing necessary to operate our business, recruit and retain qualified personnel, manage any growth we may experience and successfully realize the benefits of our previous acquisitions and any other acquisitions and collaborative arrangements we may pursue; competition from pharmaceutical companies, outsourcing facilities and pharmacies; general economic and business conditions, including inflation and supply chain challenges; regulatory and legal risks and uncertainties related to our pharmacy operations and the pharmacy and pharmaceutical business in general, including the ongoing communications with the U.S. Food and Drug Administration relating to compliance and quality plans at our outsourcing facility in New Jersey; physician interest in and market acceptance of our current and any future formulations and compounding pharmacies generally. These and additional risks and uncertainties are more fully described in Harrow’s filings with the Securities and Exchange Commission (SEC), including its Annual Report on Form 10-K for the year ended December 31, 2025, and other filings with the SEC. Such documents may be read free of charge on the SEC's web site at sec.gov. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Except as required by law, Harrow undertakes no obligation to update any forward-looking statements to reflect new information, events, or circumstances after the date they are made, or to reflect the occurrence of unanticipated events.

Contacts:
Mike Biega
Vice President of Investor Relations and Communications
[email protected]
617-913-8890

i Comparative incidence of endophthalmitis after intravitreal dexamethasone implant versus anti-VEGF injections: a retrospective study. International Journal of Retina and Vitreous. 2026

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0eb365b1-2cee-40b7-880d-fba9189e1d92

IntraGel secures up to $7 million equity investment from UroGen® to advance the Phase 2 clinical study of TumoCure, for the treatment of advanced head and neck cancer UroGen gains access to IntraGel's biodegradable sustained-release gel platform with broad potential across solid tumors, as well as an exclusive option to acquire worldwide rights to TumoCure , /PRNewswire/ -- IntraGel Therapeutics, developer of next generation long-acting injectables, today announced an equity investment agreement and a strategic Option and Research License Agreement (the Option Agreement) with UroGen Pharma Ltd. (Nasdaq: URGN), a biotechnology company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers.

In a related equity investment agreement, UroGen will invest up to $7 million in the equity securities of IntraGel, which will support the Phase 2 clinical development of TumoCure, IntraGel's investigational therapy for advanced head and neck cancer. Under the related Option Agreement, UroGen receives an exclusive option to obtain an exclusive, worldwide license to develop and commercialize TumoCure following IntraGel's completion of a Phase 2 clinical study. In addition, UroGen gains access to IntraGel's proprietary SRGel™ platform, a biodegradable sustained-release formulation technology designed for localized drug delivery, through a research license and options to obtain an exclusive, worldwide license to develop and commercialize up to three additional oncology products combining the SRGel platform with compounds to be designated by UroGen.

"UroGen's leadership in localized oncology therapies and commercial-stage experience make them an ideal collaborator to help advance the SRGel platform and accelerate the development of TumoCure," said Peter Siman, Ph.D., Chief Executive Officer and Co-Founder, IntraGel Therapeutics. "We see this collaboration as an important validation of our SRGel platform and the clinical potential of our lead investigational product, TumoCure, while creating a strong pathway to accelerate development across multiple oncology indications."

"This agreement represent an important step in expanding UroGen's oncology pipeline and our technological capabilities," said Liz Barrett, President and Chief Executive Officer of UroGen Pharma. "IntraGel's biodegradable, sustained-release technology complements our expertise in local drug delivery while creating significant optionality for future innovation. Beyond the opportunity to advance TumoCure, we believe the SRGel platform could potentially enable multiple therapeutic approaches across a range of solid tumors and provide a foundation for new product opportunities over time."

Dr. Siman added, "In parallel, we are continuing to advance additional therapeutic candidates in our pipeline based on the broadly applicable SRGel platform including our internally developed IG-003 with GLP-1 analogues for weight management, and monoclonal antibody and peptide programs developed through ongoing collaborations."

SRGel is a biodegradable depot technology designed to enable sustained release of therapeutic agents over extended periods. The platform's flexibility supports multiple therapeutic modalities and indications. In oncology, SRGel has potential applicability across a broad range of solid tumor settings, including bladder, skin, brain, gastrointestinal and testicular cancers, creating opportunities for future localized oncology treatments beyond the initial collaboration programs.

TumoCure is an investigational cisplatin product formulated with IntraGel's proprietary SRGel platform, designed to enable prolonged localized drug exposure while limiting systemic exposure. Presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Phase 1b clinical data demonstrated that TumoCure was generally safe and well tolerated, showed low systemic cisplatin exposure, and provided early indications of anti-tumor activity in a heavily pretreated patient population, including patients with cisplatin treatment-resistant disease1. Investigators also reported improvements in tumor-related symptoms in certain patients. These findings support continued clinical development of TumoCure and further expansion of the SRGel platform as a potential approach for sustained local therapy across additional solid tumors while minimizing systemic exposure.

About SRGel

SRGel is IntraGel's proprietary injectable hydrophobic gel-like drug delivery platform designed to enable sustained, tailored drug release. Built on a proprietary water-free and solvent-free fatty-acids based polymer matrix, SRGel is engineered to provide controlled, and prolonged release of therapeutics agents following a single administration, with applicability for both localized delivery at the target site and sustained systemic exposure. The technology is designed, when injected intratumorally, to maintain high local drug concentrations while minimizing systemic exposure and associated toxicities. SRGel is compatible with a broad range of therapeutic modalities, including small molecules, peptides and biologics, and may be applicable across therapeutic areas and indications, including weight loss management and inflammatory diseases.

About TumoCure

TumoCure is IntraGel's lead product candidate and the first clinical application of the SRGel platform. TumoCure consists of cisplatin incorporated into the SRGel biodegradable matrix and is administered as a single intratumoral injection. The investigational therapy is designed to provide sustained delivery of cisplatin directly within tumor tissue over several months while limiting systemic exposure. TumoCure is Phase 2-ready and is being developed for patients with locally advanced, inoperable head and neck cancers, who are ineligible for systemic cisplatin-based chemoradiation. IntraGel is pursuing development through the U.S. Federal Drug Administration (FDA)'s  505(b)(2) regulatory pathway and believes the technology may have future applicability across additional solid tumor indications, including lung, brain, gastrointestinal, ovarian and testicular cancers.

About IntraGel Therapeutics

IntraGel develops long-acting injectable therapies that can replace daily or weekly dosing with a single administration, or convert large, painful injections into small-volume, highly concentrated doses. SRGel is IntraGel's long-acting injectable platform designed to support safer, more durable treatment options across multiple therapeutic areas and modalities, including small molecules, peptides, and biologics.  IntraGel's lead product candidate based on the SRGel platform, TumoCure, for the treatment of head and neck cancer is Phase 2-ready. In addition, SRGel was shown in both in vivo and in vitro studies to deliver stable, long-acting exposure with GLP-1 analogues, monoclonal antibodies and peptides. IntraGel's technology is based on the research of Prof. Avi Domb, the School of Pharmacy, Institute for Drug Research at the Hebrew University of Jerusalem and IntraGel's Scientific Founder and Chief Scientist. The Company was established as part of NGT, a unique VC and technology incubator dedicated to investing in visionary entrepreneurs from promising early-stage healthcare startups that bring positive social impact.

Media Contact:
Tsipi Haitovsky
Global Media Liaison
[email protected]

1 J.B. Vermorken, et. al European Journal of Cancer and Clinical Oncology, 1982. 18(11): p. 1069-1074.

SOURCE IntraGel Therapeutics

Meta Platforms Inc. (NASDAQ:META) stock traded higher by almost 1% during Thursday’s premarket session as risk appetite firms up into the open. Nasdaq futures are up 0.56% while S&P 500 futures have gained 0.09%.

The Big Tech giant is scaling its AI infrastructure and developing new ways to monetize artificial intelligence as it looks to strengthen advertising growth, expand revenue sources and eventually improve margins despite elevated capital spending.

Jones Sees AI Driving Top-Line GrowthBNP Paribas analyst Nick Jones expects Meta to continue delivering robust revenue growth as it monetizes its AI investments.

The analyst reiterated an Outperform rating on Meta with an $855 price forecast, implying about 57% upside from the stock’s Aug. 18 price of $543.70.

He said Meta’s aggressive AI investments could generate “abundant revenue” over time, helping justify the company’s rising capital spending.

He sees durable growth in the company’s core advertising business, complemented over time by subscription revenue, a potential cloud offering and fees from allowing external customers to use Meta’s AI models.

Jones said Meta currently needs all of its computing capacity internally and does not expect excess capacity in the near term.

Management views monetizing AI intelligence as financially more attractive than selling raw computing power.

Meta could offer cloud capacity if its internal requirements fall short of expectations, although management expects any such arrangements to remain short-term or strategic.

SMB Advertising Offers Another Growth OpportunityJones highlighted Meta’s opportunity among small and medium-sized businesses.

Management believes AI-powered tools can help smaller companies create more personalized advertising at scale, potentially unlocking additional digital advertising spending.

Meta also continues to see robust advertising demand despite some macroeconomic pressures.

Meta Builds Its Own AI ChipsThe company plans to begin manufacturing its internally designed Meta Training and Inference Accelerator (MTIA) chips in September.

It currently uses MTIA for inference workloads that improve recommendations and rankings, with plans to broaden its applications over time.

Jones Expects Profits and Margins to ImproveJones expects Meta’s capital expenditures to continue expanding through 2027 but believes the investments will generate enough revenue over time to justify that spending.

Meta management expects operating income to increase in dollar terms in 2026, although results may fluctuate from year to year.

Combined with continued cost discipline, Jones expects margin expansion to resume as AI-driven revenue growth scales.

Analyst Consensus & Recent Actions: Meta Platforms carries a Buy consensus rating, with an average price forecast of $767.42.

On July 30, UBS maintained a Buy rating and lowered its price forecast to $715. Baird maintained an Outperform rating and cut its price forecast to $750, while Goldman Sachs maintained a Buy rating and lowered its price forecast to $725.

Top ETF Exposure First Trust Dow Jones Internet Index Fund (NYSE:FDN): 9.46% Weight Natixis Loomis Sayles Focused Growth ETF (NYSE:LSGR): 7.99% Weight Invesco Nasdaq Internet ETF (NASDAQ:PNQI): 7.66% Weight Significance: Because META carries such a heavy weight in these funds, any significant inflows or outflows for these ETFs will likely force automatic buying or selling of the stock.

Meta Price ActionMETA Stock Price Activity: Meta Platforms shares were up 0.73% at $550.00 during premarket trading on Thursday, according to Benzinga Pro data.

Image via Shutterstock

Read Next

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Erste Asset Management GmbH increased its holdings in CocaCola Company (The) (NYSE:KO – Free Report) by 56.9% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,050,768 shares of the company’s stock after buying an additional 381,076 shares during the period. CocaCola comprises about 0.7% of Erste Asset Management GmbH’s holdings, making the stock its 29th largest position. Erste Asset Management GmbH’s holdings in CocaCola were worth $86,829,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in KO. Everpar Advisors LLC raised its position in CocaCola by 0.9% during the second quarter. Everpar Advisors LLC now owns 14,504 shares of the company’s stock worth $1,179,000 after acquiring an additional 125 shares during the last quarter. Geneos Wealth Management Inc. grew its position in shares of CocaCola by 0.3% in the first quarter. Geneos Wealth Management Inc. now owns 40,879 shares of the company’s stock valued at $3,109,000 after purchasing an additional 129 shares during the last quarter. HORAN Wealth LLC increased its stake in shares of CocaCola by 3.9% during the 1st quarter. HORAN Wealth LLC now owns 3,458 shares of the company’s stock worth $263,000 after purchasing an additional 130 shares in the last quarter. Wills Financial Group LLC raised its position in shares of CocaCola by 1.3% during the 1st quarter. Wills Financial Group LLC now owns 10,170 shares of the company’s stock worth $816,000 after purchasing an additional 133 shares during the last quarter. Finally, Lee Financial Co raised its position in shares of CocaCola by 0.5% during the 2nd quarter. Lee Financial Co now owns 25,177 shares of the company’s stock worth $2,051,000 after purchasing an additional 135 shares during the last quarter. 70.26% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at CocaCola
In other CocaCola news, insider Sanket Ray sold 9,958 shares of CocaCola stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $86.50, for a total value of $861,367.00. Following the completion of the sale, the insider owned 62,105 shares in the company, valued at $5,372,082.50. The trade was a 13.82% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Bruno Pietracci sold 75,727 shares of CocaCola stock in a transaction dated Tuesday, July 28th. The shares were sold at an average price of $89.65, for a total value of $6,788,925.55. Following the completion of the sale, the insider owned 35,393 shares of the company’s stock, valued at $3,172,982.45. This trade represents a 68.15% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders sold 1,433,535 shares of company stock valued at $121,922,698. Corporate insiders own 0.90% of the company’s stock.

CocaCola Stock Up 1.8%
Shares of NYSE KO opened at $90.38 on Thursday. The firm has a market cap of $388.88 billion, a P/E ratio of 27.14, a price-to-earnings-growth ratio of 3.10 and a beta of 0.33. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.12 and a current ratio of 1.30. CocaCola Company has a 1 year low of $65.35 and a 1 year high of $90.92. The firm’s 50 day moving average price is $83.95 and its 200 day moving average price is $80.19.
CocaCola (NYSE:KO – Get Free Report) last issued its quarterly earnings results on Tuesday, July 28th. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.04. CocaCola had a return on equity of 39.38% and a net margin of 28.56%.The company had revenue of $13.37 billion during the quarter, compared to the consensus estimate of $13.17 billion. During the same period in the previous year, the firm posted $0.87 EPS. CocaCola’s revenue was up 6.2% on a year-over-year basis. CocaCola has set its FY 2026 guidance at 3.270-3.300 EPS. As a group, sell-side analysts anticipate that CocaCola Company will post 3.29 earnings per share for the current year.

CocaCola Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Tuesday, September 15th will be given a $0.53 dividend. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.3%. CocaCola’s payout ratio is currently 63.66%.

Wall Street Analysts Forecast Growth
A number of equities research analysts recently issued reports on the company. Jefferies Financial Group increased their target price on CocaCola from $95.00 to $104.00 and gave the company a “buy” rating in a report on Wednesday, July 29th. Wells Fargo & Company boosted their price target on CocaCola from $90.00 to $95.00 and gave the stock an “overweight” rating in a report on Wednesday, July 29th. JPMorgan Chase & Co. boosted their price target on CocaCola from $90.00 to $96.00 and gave the stock an “overweight” rating in a report on Wednesday, July 29th. Weiss Ratings restated a “buy (b+)” rating on shares of CocaCola in a research report on Friday, July 31st. Finally, Barclays increased their price objective on CocaCola from $91.00 to $93.00 and gave the company an “overweight” rating in a research note on Thursday, July 30th. Fifteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $95.76.

Read Our Latest Stock Analysis on CocaCola

CocaCola Profile
(Free Report)

The Coca‑Cola Company (NYSE: KO) is a global beverage manufacturer, marketer and distributor best known for its flagship Coca‑Cola soda. Headquartered in Atlanta, Georgia, the company develops and sells concentrates, syrups and finished beverages across a broad portfolio of brands. Its product range spans sparkling soft drinks, bottled water, sports drinks, juices, ready‑to‑drink teas and coffees, and other still beverages, marketed under both global and regional brand names.

Coca‑Cola’s brand portfolio includes widely recognized names such as Coca‑Cola, Diet Coke, Coca‑Cola Zero Sugar, Sprite, Fanta, Minute Maid, Powerade and Dasani, and in recent years the company has expanded into the coffee and premium beverage categories through acquisitions such as Costa Coffee.

Further Reading

Five stocks we like better than CocaCola
Bloom Energy’s AI Surge Meets a Valuation Reality Check
Target Is Winning Shoppers Back—Can the Rally Reach $180?
IonQ’s Space Contract Points to a New Frontier for Quantum Investors
Is Apple’s AI Strategy Smarter Than Skeptics Think?

Want to see what other hedge funds are holding KO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CocaCola Company (The) (NYSE:KO – Free Report).

Receive News & Ratings for CocaCola Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CocaCola and related companies with MarketBeat.com's FREE daily email newsletter.

Baldwin Investment Management LLC raised its holdings in CocaCola Company (The) (NYSE:KO – Free Report) by 127.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 28,955 shares of the company’s stock after acquiring an additional 16,235 shares during the period. Baldwin Investment Management LLC’s holdings in CocaCola were worth $2,353,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Everpar Advisors LLC grew its position in CocaCola by 0.9% during the 2nd quarter. Everpar Advisors LLC now owns 14,504 shares of the company’s stock worth $1,179,000 after acquiring an additional 125 shares during the last quarter. Geneos Wealth Management Inc. grew its holdings in CocaCola by 0.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 40,879 shares of the company’s stock worth $3,109,000 after acquiring an additional 129 shares during the period. HORAN Wealth LLC boosted its holdings in shares of CocaCola by 3.9% during the 1st quarter. HORAN Wealth LLC now owns 3,458 shares of the company’s stock worth $263,000 after buying an additional 130 shares in the last quarter. Wills Financial Group LLC increased its stake in shares of CocaCola by 1.3% in the 1st quarter. Wills Financial Group LLC now owns 10,170 shares of the company’s stock valued at $816,000 after acquiring an additional 133 shares in the last quarter. Finally, Lee Financial Co increased its stake in CocaCola by 0.5% in the second quarter. Lee Financial Co now owns 25,177 shares of the company’s stock valued at $2,051,000 after purchasing an additional 135 shares in the last quarter. Institutional investors own 70.26% of the company’s stock.

Insider Buying and Selling In other CocaCola news, insider Sanket Ray sold 9,958 shares of the business’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $86.50, for a total value of $861,367.00. Following the completion of the sale, the insider directly owned 62,105 shares of the company’s stock, valued at $5,372,082.50. The trade was a 13.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Jennifer K. Mann sold 100,000 shares of the business’s stock in a transaction dated Monday, June 8th. The shares were sold at an average price of $79.46, for a total value of $7,946,000.00. Following the completion of the sale, the executive vice president directly owned 181,384 shares of the company’s stock, valued at approximately $14,412,772.64. This trade represents a 35.54% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 1,433,535 shares of company stock worth $121,922,698 over the last 90 days. Insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets KO has been the subject of several recent research reports. Barclays boosted their price objective on CocaCola from $91.00 to $93.00 and gave the company an “overweight” rating in a report on Thursday, July 30th. Jefferies Financial Group lifted their target price on shares of CocaCola from $95.00 to $104.00 and gave the stock a “buy” rating in a research report on Wednesday, July 29th. Argus boosted their price target on shares of CocaCola from $91.00 to $97.00 and gave the stock a “buy” rating in a report on Thursday, July 30th. Wells Fargo & Company upped their price objective on CocaCola from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Wednesday, July 29th. Finally, TD Cowen increased their target price on shares of CocaCola from $90.00 to $100.00 and gave the stock a “buy” rating in a research report on Wednesday, July 29th. Fifteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, CocaCola presently has a consensus rating of “Moderate Buy” and an average price target of $95.76. Get Our Latest Research Report on KO

CocaCola Stock Up 1.8% Shares of NYSE KO opened at $90.38 on Thursday. The business has a 50-day moving average of $83.95 and a 200-day moving average of $80.19. The firm has a market capitalization of $388.88 billion, a price-to-earnings ratio of 27.14, a PEG ratio of 3.10 and a beta of 0.33. CocaCola Company has a 12 month low of $65.35 and a 12 month high of $90.92. The company has a current ratio of 1.30, a quick ratio of 1.12 and a debt-to-equity ratio of 0.97.

CocaCola (NYSE:KO – Get Free Report) last posted its quarterly earnings data on Tuesday, July 28th. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.04. The firm had revenue of $13.37 billion for the quarter, compared to analysts’ expectations of $13.17 billion. CocaCola had a net margin of 28.56% and a return on equity of 39.38%. The business’s quarterly revenue was up 6.2% on a year-over-year basis. During the same quarter last year, the company posted $0.87 EPS. CocaCola has set its FY 2026 guidance at 3.270-3.300 EPS. Sell-side analysts expect that CocaCola Company will post 3.29 earnings per share for the current fiscal year.

CocaCola Dividend Announcement The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Tuesday, September 15th will be given a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Tuesday, September 15th. CocaCola’s dividend payout ratio (DPR) is presently 63.66%.

About CocaCola (Free Report)

The Coca‑Cola Company (NYSE: KO) is a global beverage manufacturer, marketer and distributor best known for its flagship Coca‑Cola soda. Headquartered in Atlanta, Georgia, the company develops and sells concentrates, syrups and finished beverages across a broad portfolio of brands. Its product range spans sparkling soft drinks, bottled water, sports drinks, juices, ready‑to‑drink teas and coffees, and other still beverages, marketed under both global and regional brand names.

Coca‑Cola’s brand portfolio includes widely recognized names such as Coca‑Cola, Diet Coke, Coca‑Cola Zero Sugar, Sprite, Fanta, Minute Maid, Powerade and Dasani, and in recent years the company has expanded into the coffee and premium beverage categories through acquisitions such as Costa Coffee.

See Also Five stocks we like better than CocaCola Bloom Energy’s AI Surge Meets a Valuation Reality Check Target Is Winning Shoppers Back—Can the Rally Reach $180? IonQ’s Space Contract Points to a New Frontier for Quantum Investors Is Apple’s AI Strategy Smarter Than Skeptics Think?

Receive News & Ratings for CocaCola Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CocaCola and related companies with MarketBeat.com's FREE daily email newsletter.

A new chapter in the big takeover saga in the marijuana industry began on Aug. 18. U.S. multistate operator Curaleaf Holdings (CURLF +6.96%), which is vying to become the new owner of Canada's Aurora Cannabis (ACB +6.54%), formally launched a hostile bid for its peer. This came almost exactly a week after Curaleaf first publicly announced its intentions.

Owning Aurora would transform the U.S. cannabis company, changing its business profile and pushing it into new markets. That is, of course, if the attempt succeeds. But that's a story for the future; here's my take on whether Curaleaf is a buy right now.

Image source: Getty Images.

Taking it to the shareholders That morning, before the market opened, Curaleaf formally commenced its acquisition effort with a tender offering filed with the U.S. Securities and Exchange Commission.

As detailed in the announcement earlier in the month, it's offering $4 per Aurora share in a deal consisting mainly of its common stock with a smaller cash component. The bid is made up of almost 0.35 of a share of Curaleaf stock and $0.75 in cash per Aurora share.

The U.S. pot company continues to commit to a potential cap of $5 a share in total consideration should Aurora's stock price experience a "substantial" increase.

The would-be acquirer added that the $4 is 45% higher than the 30-day volume-weighted average price of Aurora's stock as of the day before the original announcement was made public. Should that cap be triggered, that premium would jump to almost 82%.

Curaleaf went hostile because of what it claimed was the lack of meaningful response from Aurora management. In a press release issued on the day of the original announcement, however, the Canadian company begged to differ. It said that its lead independent director, Michael Singer, communicated with Curaleaf Chief Executive Officer Boris Jordan as recently as July 24.

In that initial response, Aurora implied the hostile offer was inadequate. Yet it wrote that a special committee of its board of directors would be formed to evaluate it "with a view to determining the course of action that is in the best interests of the company and all stakeholders."

Aurora added that it did not intend to comment further on Curaleaf's bid until it deemed commentary appropriate. True to its word, as of early morning Wednesday, it had not published a response to Curaleaf's update.

Since a hostile takeover depends on the willingness of the target company's investors to sell their shares, Curaleaf addressed those folks in the update. It quoted Jordan as saying, "We believe this is a compelling opportunity for both companies and, most importantly, for shareholders."

Cure for the weed stock blues? I think it's compelling because Aurora is Canada's leading purveyor of medical cannabis. Yes, that's a far smaller category -- both in that market and the U.S. -- than the recreational segment, and it's harder for a cannabis company to qualify as a purveyor of medical pot.

Yet these limits help make healthcare marijuana notably more profitable when compared with recreational cannabis.

What's more, Aurora is not only heavily involved in the segment (it currently accounts for almost 95% of the company's revenue) but is also actively shipping such wares abroad. Aurora's product reaches countries that have legalized medical pot -- like Germany, where it also owns and operates a licensed marijuana growing facility.

Less than 50% of Curaleaf's cannabis sales consist of medical weed, so the category would be a critical part of the combined company's operations.

I wasn't excited about either stock after Curaleaf's original public announcement, and I'm not encouraged by the U.S. company's update.

Combining the two businesses wouldn't be quick or easy. Right off the bat, there is a fundamental regulatory mismatch between Canada, which has fully legalized pot and various derivative products, and the U.S., where the drug remains largely illegal at the federal level (although medical weed was recently rescheduled subjecting it to less onerous regulations).

On top of that, the international distribution networks are complicated, and are likely tough to consolidate. Time, effort, and resources would be needed to do this effectively. Meanwhile, despite certain advantages, neither company has proved it can be reliably and routinely profitable, and there's little indication this proposed deal will magically change once they combine.

Today's Change

(

6.96

%) $

0.64

Current Price

$

9.83

A haze of lukewarm smoke Investors haven't been falling over themselves to buy Aurora stock in anticipation of the potential marriage.

There was an initial pop after Curaleaf's original announcement, but the shares have since settled lower. They now trade at $3.67 apiece, with the discount to the proposed offer of $4 a share implying skepticism that the acquisition will go through and/or that it would create a powerhouse company if it is completed.

Adding this all up, I'd give Curaleaf stock a pass these days. I'm not seeing a great deal of potential here.

Allied Private Wealth LLC acquired a new stake in shares of NVIDIA Corporation (NASDAQ:NVDA – Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 22,476 shares of the computer hardware maker’s stock, valued at approximately $4,588,000. NVIDIA comprises approximately 2.9% of Allied Private Wealth LLC’s holdings, making the stock its 6th biggest holding.

Several other hedge funds have also recently made changes to their positions in the company. Lifetime Wealth Management P.C. acquired a new position in shares of NVIDIA in the fourth quarter valued at about $26,000. Longview Financial Advisors Inc. acquired a new stake in shares of NVIDIA during the first quarter worth about $27,000. Longfellow Investment Management Co. LLC lifted its holdings in shares of NVIDIA by 47.9% during the second quarter. Longfellow Investment Management Co. LLC now owns 207 shares of the computer hardware maker’s stock worth $33,000 after purchasing an additional 67 shares during the period. Phillip James Consulting Co. purchased a new stake in NVIDIA in the first quarter valued at approximately $40,000. Finally, Spurstone Advisory Services LLC purchased a new stake in NVIDIA in the second quarter valued at approximately $40,000. 65.27% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In
A number of equities analysts have issued reports on the stock. Jefferies Financial Group reissued a “buy” rating and set a $300.00 price target (up from $275.00) on shares of NVIDIA in a research report on Thursday, May 21st. Bank of America reaffirmed a “buy” rating and issued a $350.00 price objective (up from $320.00) on shares of NVIDIA in a report on Thursday, May 21st. Craig Hallum increased their price objective on shares of NVIDIA from $245.00 to $275.00 and gave the stock a “buy” rating in a research note on Thursday, May 21st. Tigress Financial reissued a “strong-buy” rating and set a $425.00 target price (up from $360.00) on shares of NVIDIA in a report on Wednesday, May 27th. Finally, Itau BBA Securities decreased their target price on shares of NVIDIA from $256.00 to $218.00 in a research report on Wednesday, June 24th. Three equities research analysts have rated the stock with a Strong Buy rating, forty-nine have given a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $305.94.

View Our Latest Research Report on NVDA
Insider Buying and Selling at NVIDIA
In other NVIDIA news, Director Mark A. Stevens sold 885,000 shares of NVIDIA stock in a transaction on Thursday, June 18th. The shares were sold at an average price of $210.17, for a total value of $186,000,450.00. Following the completion of the transaction, the director owned 5,207,271 shares of the company’s stock, valued at approximately $1,094,412,146.07. The trade was a 14.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Stephen C. Neal sold 15,500 shares of the company’s stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $215.73, for a total transaction of $3,343,815.00. Following the completion of the transaction, the director owned 116,135 shares of the company’s stock, valued at approximately $25,053,803.55. This trade represents a 11.77% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 1,901,125 shares of company stock valued at $410,583,015. Corporate insiders own 3.94% of the company’s stock.

Key Headlines Impacting NVIDIA
Here are the key news stories impacting NVIDIA this week:

Positive Sentiment: Potential China revenue boost: Reports indicate small shipments of NVIDIA’s H200 processors have reached mainland China, with ByteDance and Tencent reportedly receiving units. However, Beijing may restrict how the chips are used. Nvidia H200 chips reach China in small shipments
Positive Sentiment: Analyst support remains strong: Stifel reaffirmed a Buy rating and a $282 target ahead of NVIDIA’s August 26 earnings report, while Bank of America reportedly sees substantial upside based on the company’s valuation and free-cash-flow potential. Analyst updates Nvidia stock price ahead of earnings
Positive Sentiment: Supply-chain checks support the AI buildout: Stifel pointed to signals from Foxconn and Super Micro as evidence that demand for NVIDIA systems remains healthy heading into the company’s results. NVIDIA is also expanding its role by connecting Nordic GPU customers with available data-center capacity. What Foxconn and Super Micro are telling us about the AI boom
Neutral Sentiment: Mercor investment under consideration: NVIDIA is reportedly discussing an investment in AI data-labeling provider Mercor at a valuation of about $20 billion. The deal could strengthen NVIDIA’s broader AI ecosystem, but its size and terms remain unknown. Nvidia weighs investment in Mercor
Negative Sentiment: China uncertainty remains a key overhang: U.S. efforts to close loopholes allowing Chinese firms to access NVIDIA computing power through overseas data centers could limit sales, while any H200 shipments appear restricted and relatively small. U.S. export controls and Nvidia chips
Negative Sentiment: The earnings bar is high: Investors are looking beyond a routine quarterly beat and want higher forward guidance, sustained data-center growth, strong Blackwell demand, and healthy margins. This creates volatility ahead of the August 26 report. NVIDIA earnings expectations and AI demand
Negative Sentiment: Competition and concentration risks are intensifying: Investors are questioning whether custom chips, rivals such as AMD and Broadcom, and newer AI-chip startups could eventually pressure NVIDIA’s dominant position. Michael Burry discusses competition for Nvidia

NVIDIA Price Performance
Shares of NASDAQ NVDA opened at $217.56 on Thursday. The company has a debt-to-equity ratio of 0.04, a current ratio of 3.44 and a quick ratio of 2.85. The stock has a market capitalization of $5.26 trillion, a price-to-earnings ratio of 33.32, a PEG ratio of 0.44 and a beta of 2.23. The firm’s 50 day simple moving average is $207.04 and its 200-day simple moving average is $199.23. NVIDIA Corporation has a 12 month low of $164.07 and a 12 month high of $236.54.

NVIDIA (NASDAQ:NVDA – Get Free Report) last announced its quarterly earnings results on Wednesday, May 20th. The computer hardware maker reported $1.87 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.76 by $0.11. The firm had revenue of $81.61 billion for the quarter, compared to the consensus estimate of $78.42 billion. NVIDIA had a net margin of 62.97% and a return on equity of 96.94%. The firm’s quarterly revenue was up 85.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.81 earnings per share. Analysts expect that NVIDIA Corporation will post 8.59 EPS for the current year.

NVIDIA announced that its Board of Directors has approved a stock repurchase plan on Wednesday, May 20th that allows the company to repurchase $80.00 billion in outstanding shares. This repurchase authorization allows the computer hardware maker to repurchase up to 1.5% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s management believes its shares are undervalued.

NVIDIA Company Profile
(Free Report)

NVIDIA Corporation, founded in 1993 and headquartered in Santa Clara, California, is a global technology company that designs and develops graphics processing units (GPUs) and system-on-chip (SoC) technologies. Co-founded by Jensen Huang, who serves as president and chief executive officer, along with Chris Malachowsky and Curtis Priem, NVIDIA has grown from a graphics-focused chipmaker into a broad provider of accelerated computing hardware and software for multiple industries.

The company’s product portfolio spans discrete GPUs for gaming and professional visualization (marketed under the GeForce and NVIDIA RTX lines), high-performance data center accelerators used for AI training and inference (including widely adopted platforms such as the A100 and H100 series), and Tegra SoCs for automotive and edge applications.

Read More

Five stocks we like better than NVIDIA
Bloom Energy’s AI Surge Meets a Valuation Reality Check
Target Is Winning Shoppers Back—Can the Rally Reach $180?
IonQ’s Space Contract Points to a New Frontier for Quantum Investors
Is Apple’s AI Strategy Smarter Than Skeptics Think?

Want to see what other hedge funds are holding NVDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NVIDIA Corporation (NASDAQ:NVDA – Free Report).

Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter.

High liquidity is fueling booming market: Ryan Payne Payne Capital Management President Ryan Payne joins 'Mornings with Maria' to discuss the surge of private equity in sports. Billionaires like Jeff Bezos and Bob Iger are investing billions as professional sports team valuations skyrocket.

Walmart’s e-commerce sales grew in the second quarter across its major business segments.

Global e-commerce sales rose 23%, led by store-fulfilled pickup and delivery and its online marketplace, according to the company’s Q2 earnings report released Thursday.

The gains were even stronger in the U.S., where e-commerce sales increased 24%, with strength in store-fulfilled delivery, advertising and marketplace.

WALMART GOES NUCLEAR IN FIRST-OF-ITS-KIND POWER DEAL FOR RETAIL GIANT

Walmart’s e-commerce sales grew in the second quarter across its major business segments. (David Paul Morris/Bloomberg via Getty Images)

Walmart President and CEO John Furner pointed to the retailer’s online growth as a sign that customers are responding to its "price, speed and convenience."

"Our team delivered another good quarter, and we continue to make steady progress on the long-term value drivers of our business," Furner said in a statement. "Our multi-year growth in e-commerce is evidence that customers are choosing Walmart because we deliver price, speed, and convenience across a broad assortment."

WALMART CEO SAYS LOWER-INCOME SHOPPERS SHOWING 'SIGNS OF STRESS' AS FUEL COSTS SQUEEZE HOUSEHOLD BUDGETS

Walmart President and CEO John Furner pointed to the retailer’s online growth as a sign that customers are responding to its "price, speed and convenience." (Scott Olson/Getty Images)

He added, "At Walmart, they can have it all."

Sam’s Club U.S. — a major division owned and operated by Walmart — also saw strong e-commerce growth, with sales up 26%, driven by continued growth in club-fulfilled pickup and delivery, according to the report.

WALMART, SAM'S CLUB SLASH PRICES ON THOUSANDS OF PRODUCTS AS TRUMP SAYS MOVE CAME AT HIS REQUEST

Ticker Security Last Change Change % WMT WALMART INC. 114.30 -0.90 -0.78% Walmart International also posted strong e-commerce growth, with e-commerce sales rising 19%, driven by store-fulfilled pickup and delivery.

Walmart reported revenue of $187.9 billion, up 5.9% from a year earlier, and raised its outlook for the fiscal year.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

"Our business model is only getting stronger and more durable, and we’re pleased to raise our guidance for the year," John David Rainey, Walmart Inc. executive vice president and chief financial officer, said in a statement. 

Empire Life Investments Inc. reduced its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 4.6% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 144,822 shares of the company’s stock after selling 7,004 shares during the period. Johnson & Johnson comprises 2.1% of Empire Life Investments Inc.’s investment portfolio, making the stock its 12th biggest position. Empire Life Investments Inc.’s holdings in Johnson & Johnson were worth $36,780,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of JNJ. Sierra Capital LLC lifted its stake in Johnson & Johnson by 0.5% in the fourth quarter. Sierra Capital LLC now owns 8,144 shares of the company’s stock valued at $1,685,000 after purchasing an additional 41 shares during the last quarter. Beaird Harris Wealth Management LLC increased its position in Johnson & Johnson by 1.8% in the fourth quarter. Beaird Harris Wealth Management LLC now owns 2,422 shares of the company’s stock worth $501,000 after buying an additional 42 shares during the last quarter. Ballast Advisors LLC raised its stake in shares of Johnson & Johnson by 1.2% in the first quarter. Ballast Advisors LLC now owns 3,598 shares of the company’s stock valued at $879,000 after buying an additional 42 shares during the period. Crown Wealth Group LLC lifted its position in shares of Johnson & Johnson by 1.6% during the 2nd quarter. Crown Wealth Group LLC now owns 2,736 shares of the company’s stock valued at $695,000 after buying an additional 42 shares during the last quarter. Finally, Broadleaf Partners LLC lifted its position in shares of Johnson & Johnson by 0.6% during the 4th quarter. Broadleaf Partners LLC now owns 7,348 shares of the company’s stock valued at $1,521,000 after buying an additional 43 shares during the last quarter. Hedge funds and other institutional investors own 69.55% of the company’s stock.

Johnson & Johnson Price Performance Shares of NYSE JNJ opened at $273.19 on Thursday. The stock’s 50-day simple moving average is $253.89 and its two-hundred day simple moving average is $242.23. Johnson & Johnson has a twelve month low of $173.33 and a twelve month high of $276.47. The firm has a market capitalization of $658.37 billion, a P/E ratio of 31.66, a P/E/G ratio of 2.59 and a beta of 0.24. The company has a quick ratio of 0.81, a current ratio of 1.09 and a debt-to-equity ratio of 0.44.

Johnson & Johnson (NYSE:JNJ – Get Free Report) last issued its quarterly earnings results on Wednesday, July 15th. The company reported $2.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.84 by $0.06. Johnson & Johnson had a return on equity of 32.42% and a net margin of 21.48%.The firm had revenue of $25.31 billion during the quarter, compared to the consensus estimate of $25.06 billion. During the same quarter last year, the company posted $2.77 EPS. The company’s revenue for the quarter was up 6.6% on a year-over-year basis. Johnson & Johnson has set its FY 2026 guidance at 11.600-11.750 EPS. As a group, equities analysts anticipate that Johnson & Johnson will post 11.61 EPS for the current fiscal year. Johnson & Johnson Announces Dividend The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 8th. Shareholders of record on Tuesday, August 25th will be paid a $1.34 dividend. This represents a $5.36 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date of this dividend is Tuesday, August 25th. Johnson & Johnson’s payout ratio is currently 62.11%.

Wall Street Analyst Weigh In JNJ has been the subject of several recent research reports. Wall Street Zen lowered Johnson & Johnson from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Royal Bank Of Canada upped their price objective on shares of Johnson & Johnson from $265.00 to $287.00 and gave the company an “outperform” rating in a report on Monday, July 13th. Raymond James Financial set a $280.00 target price on shares of Johnson & Johnson in a research report on Monday, August 3rd. Citigroup lifted their target price on shares of Johnson & Johnson from $285.00 to $298.00 and gave the stock a “buy” rating in a research note on Wednesday, July 8th. Finally, TD Cowen boosted their price target on shares of Johnson & Johnson from $250.00 to $300.00 and gave the company a “buy” rating in a research report on Monday, July 13th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $268.22.

Check Out Our Latest Stock Report on Johnson & Johnson

Key Johnson & Johnson News Here are the key news stories impacting Johnson & Johnson this week:

Positive Sentiment: Strong earnings and higher guidance remain key catalysts. Second-quarter revenue rose 6.6% to $25.31 billion, exceeding estimates, while adjusted EPS of $2.90 topped the $2.84 consensus. Management also raised its 2026 outlook, reinforcing confidence in near-term earnings growth. Johnson & Johnson Stock Jumps as Healthcare Rotation Lifts Shares Positive Sentiment: FDA clearance expands JNJ’s medical-technology opportunity. The company received authorization for MONARCH QUEST 3, an AI-powered software upgrade adding 3D imaging, planning, and navigation capabilities to its robotic bronchoscopy platform. The development supports JNJ’s broader push into robotic surgery and advanced diagnostics. Johnson & Johnson Expands Robotic Bronchoscopy Push Positive Sentiment: Analysts continue to favor JNJ as a defensive growth and income stock. Several analysts maintain Buy or Strong Buy views, citing immunology and neuroscience medicines as potential growth engines that can help offset Stelara’s loss of exclusivity. JNJ’s 64-year record of dividend increases and recent quarterly payout of $1.34 also support its appeal to income-focused investors. Analysts Favor Dividend Aristocrats JNJ and LIN Neutral Sentiment: Above-average call-option activity points to increased short-term bullish positioning, but options flows may also increase volatility and are not a substitute for fundamental demand. Negative Sentiment: Executive Vice President Jennifer Taubert sold 15,000 shares for approximately $3.95 million, reducing her holdings by 7.16%. Continued insider selling by multiple executives could weigh modestly on sentiment, although the transaction does not by itself indicate weakening business conditions. SEC insider transaction filing Insider Activity at Johnson & Johnson In other news, EVP Elizabeth Forminard sold 15,918 shares of the stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $257.00, for a total value of $4,090,926.00. Following the transaction, the executive vice president owned 16,994 shares of the company’s stock, valued at $4,367,458. This represents a 48.37% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Vanessa Broadhurst sold 23,054 shares of the firm’s stock in a transaction on Monday, July 20th. The shares were sold at an average price of $251.27, for a total transaction of $5,792,778.58. Following the sale, the executive vice president owned 23,003 shares in the company, valued at approximately $5,779,963.81. This trade represents a 50.06% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 63,972 shares of company stock worth $16,245,605 in the last 90 days. 0.16% of the stock is currently owned by corporate insiders.

Johnson & Johnson Profile (Free Report)

Johnson & Johnson is a multinational healthcare company headquartered in New Brunswick, New Jersey, that develops, manufactures and markets a broad range of products across pharmaceuticals, medical devices and previously consumer health. Founded in 1886 by the Johnson family, the company has grown into a global healthcare organization with operations and sales in many countries around the world.

The company’s pharmaceuticals business, organized largely under its Janssen research and development organization, focuses on prescription medicines across therapeutic areas such as immunology, infectious disease, oncology and neuroscience.

Read More Five stocks we like better than Johnson & Johnson Bloom Energy’s AI Surge Meets a Valuation Reality Check Target Is Winning Shoppers Back—Can the Rally Reach $180? IonQ’s Space Contract Points to a New Frontier for Quantum Investors Is Apple’s AI Strategy Smarter Than Skeptics Think? Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ – Free Report).

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

BOCHK Asset Management Ltd lifted its position in shares of Intel Corporation (NASDAQ:INTC – Free Report) by 1,859.8% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 95,050 shares of the chip maker’s stock after purchasing an additional 90,200 shares during the quarter. Intel accounts for 2.1% of BOCHK Asset Management Ltd’s investment portfolio, making the stock its 10th largest holding. BOCHK Asset Management Ltd’s holdings in Intel were worth $13,272,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of INTC. Financially Speaking Inc increased its stake in Intel by 69.2% during the 4th quarter. Financially Speaking Inc now owns 682 shares of the chip maker’s stock valued at $25,000 after purchasing an additional 279 shares in the last quarter. Financial Life Planners bought a new position in shares of Intel in the first quarter valued at $25,000. Swiss RE Ltd. bought a new position in shares of Intel in the fourth quarter valued at $29,000. Osbon Capital Management LLC acquired a new position in shares of Intel during the fourth quarter valued at about $30,000. Finally, Beaird Harris Wealth Management LLC grew its holdings in shares of Intel by 3,185.7% during the second quarter. Beaird Harris Wealth Management LLC now owns 230 shares of the chip maker’s stock valued at $32,000 after buying an additional 223 shares during the last quarter. 64.53% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades A number of equities research analysts recently weighed in on INTC shares. Bank of America lowered their target price on shares of Intel from $160.00 to $145.00 and set a “buy” rating on the stock in a report on Wednesday, August 12th. BTIG Research upgraded Intel from a “neutral” rating to a “buy” rating in a research note on Thursday, June 11th. Daiwa Securities Group lowered Intel from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 4th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $100.00 target price on shares of Intel in a research report on Tuesday, May 12th. Finally, Moffett Nathanson downgraded Intel to a “neutral” rating in a report on Thursday, June 11th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, thirty-two have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $107.46.

Check Out Our Latest Research Report on INTC Intel Price Performance Shares of NASDAQ INTC opened at $92.80 on Thursday. The company has a market capitalization of $468.08 billion, a PE ratio of -43.98 and a beta of 2.22. The company has a quick ratio of 1.25, a current ratio of 1.60 and a debt-to-equity ratio of 0.47. The stock’s 50 day moving average price is $109.62 and its 200-day moving average price is $84.64. Intel Corporation has a twelve month low of $22.77 and a twelve month high of $142.35.

Intel (NASDAQ:INTC – Get Free Report) last issued its quarterly earnings results on Thursday, July 23rd. The chip maker reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of $0.21 by $0.21. Intel had a positive return on equity of 2.62% and a negative net margin of 19.79%.The business had revenue of $16.13 billion for the quarter, compared to analyst estimates of $14.43 billion. During the same period last year, the company posted ($0.10) earnings per share. Intel’s quarterly revenue was up 25.2% compared to the same quarter last year. Intel has set its Q3 2026 guidance at 0.380-0.380 EPS. On average, equities analysts anticipate that Intel Corporation will post 1.01 EPS for the current year.

Insider Activity at Intel In other Intel news, CEO Lip Bu Tan bought 105,263 shares of the stock in a transaction dated Tuesday, August 11th. The shares were bought at an average cost of $95.00 per share, for a total transaction of $9,999,985.00. Following the purchase, the chief executive officer directly owned 1,314,669 shares of the company’s stock, valued at approximately $124,893,555. This trade represents a 8.70% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.05% of the stock is owned by insiders.

Intel News Roundup Here are the key news stories impacting Intel this week:

Positive Sentiment: CEO Lip-Bu Tan purchased approximately $10 million of Intel stock, or more than 105,000 shares, at about $95 each. The open-market purchase signals management confidence in Intel’s turnaround, although it has not offset broader selling pressure. Insiders Are Buying Intel Positive Sentiment: Intel secured Socionext as a customer for its 18A-P process, supporting the company’s foundry strategy and suggesting progress in attracting external chip-design clients. Intel Lands Socionext for Chiplets Positive Sentiment: Analysts and industry coverage point to potential growth from AI PCs, edge AI, robotics, agentic-AI server demand and advanced packaging, where Intel is seeking to compete with Taiwan Semiconductor. The AI Boom Has a New Chip Shortage Neutral Sentiment: Intel GPU prices reportedly rose 48% in one month as memory costs increased. Higher prices could support revenue, but rising component costs may also weaken demand and margins. Intel GPU Prices Jump 48% Negative Sentiment: Intel and AMD are declining alongside a broader chip selloff tied to worries that AI infrastructure spending may be peaking. Softer sentiment toward major AI-chip demand has pressured the entire semiconductor group. Why Intel and AMD Stocks Are Falling Negative Sentiment: Investors remain concerned about dilution following Intel’s $20 billion equity offering and the stock’s sharp prior rally, which has raised valuation and profit-execution expectations. Intel’s $20 Billion Equity Raise Negative Sentiment: Recent Qualcomm testing highlighted competitive pressure from Snapdragon chips, adding to concerns about Intel’s position in client computing and power-efficient processors. Intel Stock After Snapdragon Testing Intel Company Profile (Free Report)

Intel Corporation, founded in 1968 by Robert Noyce and Gordon E. Moore and headquartered in Santa Clara, California, is a leading global designer and manufacturer of semiconductor products. The company is historically notable for introducing the first commercial microprocessor and for driving the x86 architecture that underpins many personal computers and servers. Intel’s core business spans the design, fabrication and marketing of processors, chipsets and related components for a wide range of computing applications.

Intel’s product portfolio includes client and mobile processors marketed under brands such as Intel Core and Pentium, as well as high-performance Xeon processors for data centers and cloud infrastructure.

Further Reading Five stocks we like better than Intel Bloom Energy’s AI Surge Meets a Valuation Reality Check Target Is Winning Shoppers Back—Can the Rally Reach $180? IonQ’s Space Contract Points to a New Frontier for Quantum Investors Is Apple’s AI Strategy Smarter Than Skeptics Think?

Receive News & Ratings for Intel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intel and related companies with MarketBeat.com's FREE daily email newsletter.

Charter Completes Acquisition of Liberty Broadband in All-Stock Transaction

Spectrum Brand, Pricing and Packaging to Launch in All Cox Markets Mid-September

, /PRNewswire/ -- Charter Communications, Inc. (NASDAQ: CHTR) (along with its subsidiaries, "Charter") today announced that it has completed its previously announced transaction with Cox Communications ("Cox") and the acquisition of Liberty Broadband Corporation ("Liberty Broadband"). These transformative transactions create the leading broadband and video company in the nation and the fastest growing mobile provider in its footprint, with seamless connectivity and video entertainment, and high-quality customer service delivering powerful benefits for customers, local communities, employees and shareholders.

"The addition of Cox to the Spectrum footprint is one that can be celebrated by customers, employees and investors alike," said Chris Winfrey, Charter President and CEO. "Together, we will bring the best products, at the best price, coupled with the highest level of customer service to more customers across our expanded 45-state Spectrum footprint. And Cox employees will soon have access to all the programs and benefits that have made Charter an employer of choice where its 100% U.S.-based employees can build long-term careers.

"The market has changed considerably over the past decade, and regional providers like Spectrum are competing with national and even global connectivity and entertainment companies. Today, with expanded scale, we are better positioned to compete and continue investment in our products and service, tools and platforms, and to further the capability and reach of our Spectrum Fiber Broadband Network."

Eric Zinterhofer, who prior to closing the transactions had served as Chairman of Charter's board, added, "Congratulations to Chris, the Charter team and the Cox family for completing an industry-transforming transaction. I look forward to serving as lead independent director as Alex Taylor becomes Charter's next Chairman."

"When Liberty first invested in Charter more than a decade ago, we saw an opportunity to build scale behind a great management team and operating model," said Dr. John C. Malone, Chairman of Liberty Broadband. "The combination of Charter and Cox creates a stronger, more competitive company to further invest and innovate, while giving Liberty Broadband shareholders a direct interest in its future. I have tremendous respect for the Cox family and its long tradition of entrepreneurial leadership and responsible stewardship, and I look forward to seeing what Chris, Alex and their teams accomplish together."

The Cox Transaction

A subsidiary of Cox Enterprises, Inc. ("Cox Enterprises") received:

Approximately 33.6 million common units in Charter's existing partnership ("Charter Holdings"), with an implied value of approximately $5 billion, and which are exchangeable for Charter common shares.  $6 billion of convertible preferred units of Charter Holdings, with a 6.875% coupon, which are convertible into 12.6 million common units of Charter Holdings, and which are exchangeable for Charter common shares. And a total of approximately $4 billion in cash. In aggregate, Charter issued the equivalent of just over 46 million Charter shares to a subsidiary of Cox Enterprises. Based on Charter's share count as of June 30, 2026, and giving effect to the closing of the Liberty Broadband merger and the Cox transaction, Cox Enterprises and its subsidiaries now own approximately 26% of the combined entity's fully diluted shares outstanding, on an as-converted, as-exchanged basis. Additionally, approximately $12 billion of Cox debt and finance leases will remain outstanding at subsidiaries of Charter as a result of the transaction.

Alex Taylor, Chairman and CEO of Cox Enterprises and Chairman of Charter's Board of Directors said, "For generations, my family has believed in building businesses that matter and stand the test of time. The broadband industry has shaped how people live, work and connect with one another, and we believe deeply in its future. I look forward to partnering with Chris and the board to build on a proud legacy and create long-term value for our shareholders, customers, employees and the communities we serve."

The Liberty Broadband Transaction

Concurrent with the closing of the Cox transaction, Charter closed its transaction with Liberty Broadband. Under the terms of the agreement, each holder of Liberty Broadband Series A common stock, Series B common stock, and Series C common stock (collectively, "Liberty Broadband common stock") received 0.236 of a share of Charter common stock per share of Liberty Broadband common stock held, with cash paid in lieu of fractional shares. Each holder of Liberty Broadband Series A cumulative redeemable preferred stock ("Liberty Broadband preferred stock") received one share of newly issued Charter cumulative redeemable preferred stock ("Charter preferred stock") per share of Liberty Broadband preferred stock held, which Charter preferred stock will substantially mirror the current terms of the Liberty Broadband preferred stock.

As a result of the transaction, Charter retired approximately 38.6 million Charter shares previously owned by Liberty Broadband and issued approximately 33.9 million shares to holders of Liberty Broadband common stock at closing, resulting in a net decrease of approximately 4.7 million Charter shares outstanding. At close, Charter assumed approximately $840 million of Liberty Broadband net debt that will be repaid shortly after closing, and $180 million of preferred equity that became Charter preferred equity upon the close of the transaction.

Customer, Community and Employee Benefits

Beginning today, Spectrum will offer Cox customers a free mobile line for one year

To welcome its new customers, Spectrum is offering a free year of mobile service to Cox internet customers who don't already subscribe to Cox Mobile; the first of many benefits Spectrum will offer. In mid-September, Spectrum plans to launch its entire suite of products to all consumers, including existing customers, in former Cox markets offering Spectrum's simple and transparent pricing and packaging, greater value and more opportunities to save.

Spectrum Internet and Spectrum Mobile work together over the Spectrum Fiber Broadband Network and are supported by approximately 45 million WiFi access points across the country, delivering a faster, more seamless experience than standalone 5G. Spectrum's Seamless Connectivity bundle delivers the most reliable service and helps customers save with Spectrum's $1,000 savings guarantee.

For Video, Spectrum's Seamless Entertainment brings live TV and popular streaming apps together, all in one place. Spectrum TV Select plans include ad-supported streaming apps like Disney+, Hulu, ESPN Unlimited, Discovery+, HBO MAX, Paramount+, Peacock, AMC+, ViX, Tennis Channel, and FOX One, providing up to $127 of monthly retail value at no extra cost. The Spectrum TV App, the highest-rated pay TV streaming app and the most viewed streaming service in the U.S. on an hours per household basis, lets customers stream, pause, and rewind live TV, plus watch On Demand and DVR, on phones, tablets and the most popular streaming devices. And with the Xumo Stream Box with voice remote, Spectrum makes it easy to search and switch between live TV and the most popular streaming apps.

Within the next year, Cox customers also will benefit from Spectrum's industry-first Customer Service Commitments, which include:

100% U.S.-based customer service team available 24/7. fixing service disruptions quickly, including same-day technician dispatch when requested before 5:00 pm; if not, the next day. providing customers with credits for outages that last longer than two hours. To achieve those commitments, over the next 18 months Spectrum will apply its sales and service workforce model to Cox markets, and will fully return Cox's customer service function to the U.S.  All employees will earn a starting wage of at least $20 per hour and enjoy Spectrum's industry-leading benefits, which include:

Comprehensive medical, dental, and vision coverage for all full-time and part-time employees. Market-leading retirement benefits, including a 401(k) plan with a company match up to 6% of their eligible pay. Free or discounted Spectrum Mobile, TV and Internet service. Multiple opportunities for upward advancement to build careers, including through self-progression programs with standardized pay raises, and formal development programs, including the Broadband Field Technician Apprenticeship program. Tuition-free undergraduate degree and certificate programs via flexible online learning. The Employee Stock Purchase Plan provides all frontline employees with the ability to purchase stock and receive a matching grant of Charter Restricted Stock Units (RSUs) up to 1-for-1 based on years of service. Participation in the Invest in America Trump Accounts program, matching the federal government's $1,000 contribution for employees' children. Businesses of all sizes throughout the Spectrum footprint will benefit from the combination of Spectrum Business with Cox Business' well-known industry leadership, including Segra, Cox's super-regional, fiber-based provider serving commercial enterprise and carrier customers, and RapidScale, its managed, cloud-based services provider. 

In advertising, Spectrum will expand opportunities for advertisers large and small, national, regional, and local, bringing new competition in an area now dominated by Big Tech.

Spectrum is a local company that helps create opportunities and invests in the communities where its employees live and work with programs focused on increasing digital inclusion and education, promoting critical human services (including food security, housing, and employment), and supporting small businesses. Spectrum established the Spectrum Foundation with a $50 million initial investment to respond to local needs, expand economic opportunity and empower communities to thrive.

Spectrum's local presence in the communities is furthered by Spectrum Networks, its award-winning news division with more than 35 stations across the company's footprint, providing objective reporting from local journalists, ensuring coverage reflects and is informed by the issues that matter most to our communities. In the coming months, Spectrum Networks will expand its presence into the Cox footprint, bringing local, unbiased news coverage to more communities in new DMAs. 

Governance

Mr. Alex Taylor has been appointed Chairman, and Mr. Eric Zinterhofer has been named the lead independent director of Charter's board. Mr. Winfrey will continue in his current role as President and CEO and board member. In addition to Mr. Taylor, Cox Enterprises has appointed Mr. Dallas Clement and Mr. Mark Greatrex to Charter's 13-member board.

Advance/Newhouse, which, like Cox, contributed its operations to Charter's partnership in 2016, will retain its two board seats held by Mr. Steve Miron and Mr. Michael Newhouse.

At close, Liberty Broadband ceased to be a direct shareholder in Charter and no longer designates directors for election to the Charter board. Mr. Martin Patterson and Mr. J. David Wargo have stepped down from the board, effective as of the close of the transaction. In addition, Mr. John Markley Jr. retired from the Charter board effective as of the close of the transaction and Mr. Balan Nair will continue to serve on the Charter board as an independent director.

Charter, Cox Enterprises and Advance/Newhouse entered into an amended and restated stockholders' agreement, which provided for preemptive rights over certain issuances, voting caps and required participation in Charter common share repurchases at specified acquisition caps, and transfer restrictions among other shareholder governance matters.

Within a year following the transaction, the company will change its parent company name to Cox Communications but will continue to operate as Spectrum across all markets. The Company also will remain headquartered in Stamford, CT, keeping a significant presence in Atlanta, GA.  

In the Cox transaction, Citi and LionTree served as financial advisors and Wachtell, Lipton, Rosen & Katz served as legal counsel to Charter. Allen & Company served as financial advisor to Cox Enterprises. BDT & MSD Partners, Evercore and Wells Fargo served as financial advisors to Cox. Latham & Watkins LLP served as legal advisor to Cox Enterprises.

In the Liberty Broadband transaction, Centerview Partners LLC served as exclusive financial advisor to the special committee of Charter. Citi served as exclusive financial advisor to Charter. Wachtell, Lipton, Rosen & Katz served as legal counsel to the special committee of Charter. J.P. Morgan served as exclusive financial advisor to Liberty Broadband, and O'Melveny & Myers LLP served as legal counsel to Liberty Broadband.

About Charter
Charter Communications, Inc. (NASDAQ: CHTR) is the leading broadband and video company in the nation and the fastest growing mobile provider in its footprint, with services available to more than 70 million homes and small to large businesses across 45 states through its Spectrum brand. Founded in 1993, Charter has evolved from providing cable TV to streaming, and from high-speed Internet to a converged broadband, WiFi and mobile experience. Over the Spectrum Fiber Broadband Network and supported by our 100% U.S.-based employees, the Company offers Seamless Connectivity and Entertainment with Spectrum Internet®, Mobile, TV and Voice products. 

More information can be found at corporate.charter.com.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This communication includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our plans, strategies and prospects, both business and financial.  Although we believe that our plans, intentions and expectations as reflected in or suggested by these forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions or expectations. Forward-looking statements are inherently subject to risks, uncertainties and assumptions including, without limitation: (i) our ability to successfully integrate the Cox Communications business; (ii) the ultimate outcome and results of integrating operations and application of Charter's operating strategies to the Cox Communications business and the ultimate ability to realize synergies at the levels currently expected as well as potential dis-synergies; (iii) the impact of the transaction on our stock price and future operating results, including due to transaction and integration costs, increased interest expense, business disruption, and diversion of management time and attention; (iv) the reduction in our current stockholders' percentage ownership and voting interest as a result of the transaction; (v) the increase in our indebtedness as a result of the transaction, which will increase interest expenses and may decrease our operating flexibility; (vi) other risks related to the transaction and actions related thereto; and (vii) the factors described under "Risk Factors" from time to time in our filings with the SEC.   Many of the forward-looking statements contained in this communication may be identified by the use of forward-looking words such as "believe," "future," "expect," "anticipate," "should," "planned," "will," "may," "intend," "estimated," "aim," "on track," "target," "opportunity," "tentative," "positioning," "designed," "create," "predict," "project," "initiatives," "seek," "would," "could," "continue," "ongoing," "upside," "increases," "grow," "focused on" and "potential," among others.   Important factors that could cause actual results to differ materially from the forward-looking statements we make in this communication are set forth in our annual report on Form 10-K, and in other reports or documents that we file from time to time with the SEC.

All forward-looking statements speak only as of the date they are made and are based on information available at that time. We assume no obligation to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements were made or to reflect the occurrence of unanticipated events except as required by federal securities laws. As forward-looking statements involve significant risks and uncertainties, caution should be exercised against placing undue reliance on such statements.

SOURCE Charter Communications, Inc.

Disciplined execution drives stronger-than-expected results in a dynamic market. Net income guidance improved to $4.75 billion to $5.00 billion. Order book trends reinforce 2026 as the bottom of the ag equipment cycle. , /PRNewswire/ -- Deere & Company (NYSE: DE) reported net income of $1.379 billion for the third quarter ended August 2, 2026, or $5.10 per share, compared with net income of $1.289 billion, or $4.75 per share, for the quarter ended July 27, 2025. For the first nine months of the year, net income attributable to Deere & Company was $3.808 billion, or $14.06 per share, compared with $3.962 billion, or $14.57 per share, for the same period last year.

Production & Precision Agriculture Operating Profit Third Quarter 2026 Compared to Third Quarter 2025 $ in millions

Small Agriculture & Turf Operating Profit Third Quarter 2026 Compared to Third Quarter 2025 $ in millions

Construction & Forestry Operating Profit Third Quarter 2026 Compared to Third Quarter 2025 $ in millions Worldwide net sales and revenues increased 5 percent, to $12.608 billion, for the third quarter of 2026 and rose 7 percent, to $35.589 billion, for nine months. Net sales were $10.999 billion for the quarter and $30.779 billion for nine months, compared with $10.357 billion and $28.338 billion last year, respectively.

"Deere delivered a strong quarter, reflecting disciplined execution by our teams and continued resilience across our portfolio," said John C. May, chairman and chief executive officer. "Our performance underscores the strength of our business, supported by stable U.S. market conditions, our ability to manage softer conditions in Brazil and Europe, and our commitment to helping customers succeed."

Company Outlook & Summary

Net income attributable to Deere & Company for fiscal 2026 is forecasted to be in a range of $4.75 billion to $5.00 billion.

"As we look ahead, we continue to believe 2026 will mark the bottom of the current ag equipment cycle," May said. "Across our business, early order program trends, improving used-equipment inventories, and increasing customer adoption of our advanced technologies give us confidence that Deere is well positioned for long-term value creation."

Deere & Company

Third Quarter

Year to Date

$ in millions, except per share amounts

2026

2025

% Change

2026

2025

% Change

Net sales and revenues

$

12,608

$

12,018

5 %

$

35,589

$

33,290

7 %

Net income

$

1,379

$

1,289

7 %

$

3,808

$

3,962

-4 %

Fully diluted EPS

$

5.10

$

4.75

$

14.06

$

14.57

Results for the prior periods presented were affected by special items. See Note 2 of the financial statements for further details. The company recorded tariff recoveries in the third quarter and first nine months of 2026 of $110 million and $382 million, respectively. The tariff impact for each segment is primarily included in the "Production Costs" category below.

Production & Precision Agriculture

Third Quarter

$ in millions

2026

2025

% Change

Net sales

$

3,998

$

4,273

-6 %

Operating profit

$

527

$

580

-9 %

Operating margin

13.2 %

13.6 %

Production & Precision Agriculture sales decreased for the quarter as a result of lower shipment volumes, partially offset by favorable price realization and foreign currency translation. Operating profit decreased primarily due to lower shipment volumes / sales mix and higher production costs, partially offset by favorable price realization and the effects of foreign currency exchange.

Small Agriculture & Turf

Third Quarter

$ in millions

2026

2025

% Change

Net sales

$

3,383

$

3,025

12 %

Operating profit

$

622

$

485

28 %

Operating margin

18.4 %

16.0 %

Small Agriculture & Turf sales increased for the quarter as a result of higher shipment volumes and favorable price realization. Operating profit increased primarily due to higher shipment volumes / sales mix and favorable price realization, partially offset by higher production costs.

Construction & Forestry

Third Quarter

$ in millions

2026

2025

% Change

Net sales

$

3,618

$

3,059

18 %

Operating profit

$

436

$

237

84 %

Operating margin

12.1 %

7.7 %

Construction & Forestry sales increased for the quarter primarily as a result of higher shipment volumes and favorable price realization. Operating profit increased primarily due to favorable price realization, partially offset by higher SA&G and R&D costs.

Financial Services

Third Quarter

$ in millions

2026

2025

% Change

Net income

$

219

$

205

7 %

Financial Services net income increased primarily due to favorable financing spreads, partially offset by the impact of a lower average portfolio.

Industry Outlook for Fiscal 2026

Agriculture & Turf

U.S. & Canada:

Large Ag

Down 15 to 20%

Small Ag & Turf

Flat to up 5%

Europe

Flat

South America (Tractors & Combines)

Down 15 to 20%

Asia

Flat

Construction & Forestry

U.S. & Canada:

Construction Equipment

Up 5 to 10%

Compact Construction Equipment

Up ~5%

Global Forestry

Down ~10%

Global Roadbuilding

Up ~10%

Deere Segment Outlook for Fiscal 2026

Currency

Price

$ in millions

Net Sales

Translation

Realization

Production & Precision Ag

Down ~10%

+2.5 %

~ +1.0%

Small Ag & Turf

Up ~15%

+0.5 %

~ +1.5%

Construction & Forestry

Up ~20%

+1.5 %

~ +3.0%

Financial Services

Net Income

~ $870

FORWARD-LOOKING STATEMENTS

Certain statements contained herein, including in the sections entitled "Company Outlook & Summary," "Industry Outlook for Fiscal 2026," "Deere Segment Outlook for Fiscal 2026," and "Condensed Notes to Interim Consolidated Financial Statements" relating to future events, expectations, and trends constitute "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 and involve factors that are subject to change, assumptions, risks, and uncertainties that could cause actual results to differ materially. Some of these risks and uncertainties could affect all lines of the company's operations generally, while others could more heavily affect a particular line of business.

Forward-looking statements are based on information currently available to the company and the company's current assumptions, expectations, and projections about future events and should not be relied upon. Except as required by law, the company expressly disclaims any obligation to update or revise its forward-looking statements. Many factors, risks, and uncertainties could cause actual results to differ materially from these forward-looking statements. Among these factors are risks related to:

the agricultural business cycle, which can be unpredictable and is affected by factors such as farm income, international trade, world grain stocks, crop yields, available farm acres, soil conditions, prices for commodities and livestock, input costs including the availability and price of fertilizer, government farm programs, and availability of transport for crops construction and forestry activity, which is affected by factors such as housing starts and supply, real estate and housing prices, levels of residential and non-residential construction, public and private infrastructure development, and government policies and regulations macroeconomic conditions, including unemployment, inflation, interest rate volatility, energy price increases resulting from geopolitical conflicts, changes in consumer sentiment and practices due to slower economic growth or a recession, and regional or global liquidity constraints the uncertainty of government policies and actions with respect to the global trade environment, including increased and contested tariffs announced by the U.S. government and retaliatory trade regulations political, economic, and social instability in the geographies in which the company operates worldwide demand for food and different forms of renewable energy impacting the price of farm commodities and the resulting impacts on the demand for the company's equipment rationalization, restructuring, relocation, expansion, and/or reconfiguration of manufacturing and warehouse facilities accurately forecasting customer demand for products and services, and adequately managing inventory selling products domestically or internationally, managing increased costs of production, absorbing or passing on increased expenses, as well as accurately predicting financial results and industry trends availability and price of raw materials, components, and whole goods delays or disruptions in the company's supply chain, including those arising from geopolitical conflicts changes in climate patterns, unfavorable weather events, and natural disasters suppliers' and manufacturers' business practices and compliance with applicable laws such as human rights, safety, environmental, and fair wages higher interest rates and currency fluctuations which could adversely affect the U.S. dollar, customer confidence, access to capital, and demand for the company's products and solutions attracting, developing, engaging, and retaining qualified employees adapting in highly competitive markets, including understanding and meeting customers' changing expectations for products and solutions, including delivery and utilization of precision technology realizing the anticipated benefits of the company's Smart Industrial Operating Model, achieving the company's Leap Ambitions, and executing the company's related business strategies in production systems, precision technologies, and aftermarket support the company's dealer network's development and implementation of successful sales plans, management of new and used inventory, distribution of the company's products, and support and service for the company's precision technology solutions achieving anticipated benefits of acquisitions and joint ventures, including challenges with successfully integrating operations and internal control processes negative claims or publicity that damage the company's reputation or brand the impact of workforce reductions on company culture, employee retention and morale, and institutional knowledge labor relations and contracts, including work stoppages and other disruptions security breaches, cybersecurity attacks, technology failures, and other disruptions to the company's information technology infrastructure and products leveraging artificial intelligence and machine learning within the company's business processes changes to existing laws and regulations, including the implementation of new, more stringent laws, as well as compliance with a variety of U.S., foreign, and international laws, regulations, and policies relating to, but not limited to the following: advertising, anti-bribery and anti-corruption, anti-money laundering, antitrust, consumer finance, cybersecurity, data privacy, encryption, environment (including climate change and engine emissions), farming, foreign exchange controls and cash repatriation restrictions, foreign ownership and investment, health and safety, human rights, import / export and trade, labor and employment, product liability, right-to-repair, tariffs, tax, telematics, and telecommunications governmental and other actions designed to address climate change in connection with a transition to a lower-carbon economy warranty claims, post-sales repairs or recalls, product liability litigation, and regulatory investigations because of the deficient operation of the company's products investigations, claims, lawsuits, or other legal proceedings loss of or challenges to intellectual property rights Further information concerning the company or its businesses, including factors that could materially affect the company's financial results, is included in the company's other filings with the SEC (including, but not limited to, the factors discussed in Item 1A. "Risk Factors" of the company's most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q). There also may be other factors that the company cannot anticipate or that are not described herein because the company does not currently perceive them to be material.

DEERE & COMPANY

THIRD QUARTER 2026 PRESS RELEASE

(In millions of dollars) Unaudited

Three Months Ended

Nine Months Ended

August 2

July 27

%

August 2

July 27

%

2026

2025

Change

2026

2025

Change

Net sales and revenues:

Production & Precision Ag net sales

$

3,998

$

4,273

-6

$

11,664

$

12,571

-7

Small Ag & Turf net sales

3,383

3,025

+12

9,036

7,767

+16

Construction & Forestry net sales

3,618

3,059

+18

10,079

8,000

+26

Financial Services revenues

1,371

1,418

-3

4,121

4,273

-4

Other revenues

238

243

-2

689

679

+1

Total net sales and revenues

$

12,608

$

12,018

+5

$

35,589

$

33,290

+7

Operating profit: *

Production & Precision Ag

$

527

$

580

-9

$

1,372

$

2,066

-34

Small Ag & Turf

622

485

+28

1,538

1,182

+30

Construction & Forestry

436

237

+84

1,134

681

+67

Financial Services

271

266

+2

823

740

+11

Total operating profit

1,856

1,568

+18

4,867

4,669

+4

Reconciling items **

52

60

-13

184

198

-7

Income taxes

(529)

(339)

+56

(1,243)

(905)

+37

Net income attributable to Deere & Company

$

1,379

$

1,289

+7

$

3,808

$

3,962

-4

*

Operating profit is income from continuing operations before corporate expenses, certain external interest expenses, certain foreign exchange gains and losses, and income taxes. Operating profit of Financial Services includes the effect of interest expense and foreign exchange gains and losses.

**

Reconciling items are primarily corporate expenses, certain interest income and expenses, certain foreign exchange gains and losses, pension and postretirement benefit costs excluding the service cost component, and net income attributable to noncontrolling interests.

DEERE & COMPANY

STATEMENTS OF CONSOLIDATED INCOME

For the Three and Nine Months Ended August 2, 2026 and July 27, 2025

(In millions of dollars and shares except per share amounts) Unaudited

Three Months Ended

Nine Months Ended

2026

2025

2026

2025

Net Sales and Revenues

Net sales

$

10,999

$

10,357

$

30,779

$

28,338

Finance and interest income

1,353

1,426

4,011

4,233

Other income

256

235

799

719

Total

12,608

12,018

35,589

33,290

Costs and Expenses

Cost of sales

7,939

7,570

22,486

20,215

Research and development expenses

567

556

1,704

1,631

Selling, administrative and general expenses

1,220

1,217

3,401

3,387

Interest expense

710

794

2,141

2,408

Other operating expenses

290

281

846

817

Total

10,726

10,418

30,578

28,458

Income of Consolidated Group before Income Taxes

1,882

1,600

5,011

4,832

Provision for income taxes

529

339

1,243

905

Income of Consolidated Group

1,353

1,261

3,768

3,927

Equity in income of unconsolidated affiliates

24

10

34

11

Net Income

1,377

1,271

3,802

3,938

Less: Net loss attributable to noncontrolling interests

(2)

(18)

(6)

(24)

Net Income Attributable to Deere & Company

$

1,379

$

1,289

$

3,808

$

3,962

Per Share Data

Basic

$

5.11

$

4.76

$

14.10

$

14.61

Diluted

5.10

4.75

14.06

14.57

Dividends declared

1.62

1.62

4.86

4.86

Dividends paid

1.62

1.62

4.86

4.71

Average Shares Outstanding

Basic

269.8

270.7

270.1

271.1

Diluted

270.7

271.4

270.8

271.9

See Condensed Notes to Interim Consolidated Financial Statements.

DEERE & COMPANY

CONDENSED CONSOLIDATED BALANCE SHEETS

(In millions of dollars) Unaudited

August 2

November 2

July 27

2026

2025

2025

Assets

Cash and cash equivalents

$

8,928

$

8,276

$

8,580

Marketable securities

1,350

1,411

1,407

Trade accounts and notes receivable – net

7,723

5,317

6,103

Financing receivables – net

42,860

44,575

43,930

Financing receivables securitized – net

6,316

6,831

7,948

Other receivables

2,466

2,403

2,826

Equipment on operating leases – net

7,400

7,600

7,512

Inventories

7,811

7,406

7,713

Property and equipment – net

8,006

8,079

7,713

Goodwill

4,466

4,188

4,209

Other intangible assets – net

940

892

926

Retirement benefits

3,541

3,273

3,182

Deferred income taxes

2,343

2,284

2,209

Other assets

3,457

3,461

3,559

Total Assets

$

107,607

$

105,996

$

107,817

Liabilities and Stockholders' Equity

Liabilities

Short-term borrowings

$

17,115

$

13,796

$

14,607

Short-term securitization borrowings

6,095

6,596

7,610

Accounts payable and accrued expenses

13,668

13,909

13,582

Deferred income taxes

411

434

489

Long-term borrowings

40,626

43,544

44,429

Retirement benefits and other liabilities

1,651

1,710

1,836

Total liabilities

79,566

79,989

82,553

Redeemable noncontrolling interest

44

51

84

Stockholders' Equity

Total Deere & Company stockholders' equity

27,990

25,950

25,175

Noncontrolling interests

7

6

5

Total stockholders' equity

27,997

25,956

25,180

Total Liabilities and Stockholders' Equity

$

107,607

$

105,996

$

107,817

See Condensed Notes to Interim Consolidated Financial Statements.

DEERE & COMPANY

STATEMENTS OF CONSOLIDATED CASH FLOWS

For the Nine Months Ended August 2, 2026 and July 27, 2025

(In millions of dollars) Unaudited

2026

2025

Cash Flows from Operating Activities

Net income

$

3,802

$

3,938

Adjustments to reconcile net income to net cash provided by operating activities:

Provision for credit losses

205

258

Depreciation and amortization

1,787

1,668

Impairments and other adjustments

29

Share-based compensation expense

116

104

Credit for deferred income taxes

(61)

(102)

Changes in assets and liabilities:

Receivables related to sales

(1,252)

(494)

Inventories

(443)

(526)

Accounts payable and accrued expenses

(266)

(717)

Accrued income taxes payable/receivable

(119)

(147)

Retirement benefits

(367)

(813)

Other

(152)

266

Net cash provided by operating activities

3,250

3,464

Cash Flows from Investing Activities

Collections of receivables (excluding receivables related to sales)

19,922

19,712

Proceeds from maturities and sales of marketable securities

389

359

Proceeds from sales of equipment on operating leases

1,479

1,408

Cost of receivables acquired (excluding receivables related to sales)

(19,139)

(18,962)

Acquisitions of businesses, net of cash acquired

(455)

(89)

Purchases of marketable securities

(361)

(598)

Purchases of property and equipment

(716)

(852)

Cost of equipment on operating leases acquired

(1,933)

(2,009)

Collections of receivables from unconsolidated affiliates

197

334

Collateral on derivatives – net

(63)

127

Other

(145)

(231)

Net cash used for investing activities

(825)

(801)

Cash Flows from Financing Activities

Net proceeds (payments) in short-term borrowings (original maturities three months or less)

3,205

(2,060)

Proceeds from borrowings issued (original maturities greater than three months)

5,373

10,707

Payments of borrowings (original maturities greater than three months)

(8,338)

(7,743)

Repurchases of common stock

(697)

(1,136)

Dividends paid

(1,316)

(1,282)

Other

(55)

(43)

Net cash used for financing activities

(1,828)

(1,557)

Effect of Exchange Rate Changes on Cash, Cash Equivalents, and Restricted Cash

20

108

Net Increase in Cash, Cash Equivalents, and Restricted Cash

617

1,214

Cash, Cash Equivalents, and Restricted Cash at Beginning of Period

8,533

7,633

Cash, Cash Equivalents, and Restricted Cash at End of Period

$

9,150

$

8,847

See Condensed Notes to Interim Consolidated Financial Statements.

DEERE & COMPANY
Condensed Notes to Interim Consolidated Financial Statements
(In millions of dollars) Unaudited

(1)

Acquisitions

In 2026, the company completed several acquisitions to advance the capabilities of its existing technology offerings, including the February acquisition of Tenna LLC (Tenna), a U.S. construction technology company that provides mixed-fleet equipment operations and asset tracking solutions, for a purchase price of $439 million, net of cash acquired. Tenna was assigned to the CF segment. The company also acquired other small-scale businesses assigned to the PPA, SAT, and CF segments for a combined purchase price consideration of $16 million, net of cash acquired. Most of the purchase price for these acquisitions was allocated to goodwill and other intangible assets.

In 2025, the company acquired businesses to advance the capabilities of the company's existing technology offerings, providing customers with a more comprehensive set of tools to generate and use data to make decisions that improve profitability, efficiency, and sustainability. The combined cost of these acquisitions was $89 million, net of cash acquired. The businesses were assigned to the PPA and CF segments. Most of the purchase price for these acquisitions was allocated to goodwill and other intangible assets.

(2)

Special Items

Impairment

In the third quarter of 2025, the company recorded a non-cash charge of $61 million pretax ($49 million after-tax), primarily related to the trade name and customer relationship assets of external overseas battery operations. Of this amount, $53 million was recorded in "Selling, administrative and general expenses" and $8 million in "Cost of sales." The charge is presented in "Impairments and other adjustments" in the statements of consolidated cash flows. The impairment resulted from slowing external demand for batteries, which indicated that it is probable future cash flows would not cover the carrying value of the assets.

Discrete Tax Items

In the first quarter of 2025, the company recorded favorable net discrete tax items primarily due to tax benefits of $110 million related to the realization of foreign net operating losses from the consolidation of certain subsidiaries and $53 million from an adjustment to an uncertain tax position of a foreign subsidiary.

Banco John Deere S.A.

In 2024, the company entered into an agreement with a Brazilian bank, Banco Bradesco S.A. (Bradesco), for Bradesco to invest and become a 50% owner of the company's wholly-owned subsidiary in Brazil, Banco John Deere S.A. (BJD). BJD finances retail and wholesale loans for agricultural, construction, and forestry equipment. The transaction is intended to reduce the company's incremental risk as it continues to grow in the Brazilian market.

The BJD business was reclassified as held for sale in 2024. In January 2025, the valuation allowance on assets held for sale decreased, resulting in a pretax and after-tax gain (reversal of previous losses) of $32 million recorded in "Selling, administrative and general expenses" in the nine months ended July 27, 2025. The valuation allowance changes are presented in "Impairments and other adjustments" in the statements of consolidated cash flows.

The company deconsolidated BJD upon completion of the transaction in February 2025. The company accounts for its investment in BJD using the equity method of accounting and results of its operations are reported in "Equity in income (loss) of unconsolidated affiliates" within the Financial Services segment. The company reports investments in unconsolidated affiliates and receivables from unconsolidated affiliates in "Other assets" and "Other receivables," respectively.

Summary of 2025 Special Items

The following table summarizes the operating profit impact of the special items recorded in millions of dollars for the three months and nine months ended July 27, 2025.

Three Months

Nine Months

PPA

SAT

CF

FS

Total

PPA

SAT

CF

FS

Total

2025 Expense (benefit):

Impairment

$

28

$

17

$

16

$

61

$

28

$

17

$

16

$

61

BJD measurement

$

(32)

(32)

Total expense (benefit)

$

28

$

17

$

16

$

61

$

28

$

17

$

16

$

(32)

$

29

(3)

The consolidated financial statements represent the consolidation of all the company's subsidiaries. The supplemental consolidating data in Note 4 to the financial statements is presented for informational purposes. Equipment operations represent the enterprise without Financial Services. Equipment operations include the company's Production & Precision Agriculture operations, Small Agriculture & Turf operations, Construction & Forestry operations, and other corporate assets, liabilities, revenues, and expenses not reflected within Financial Services. Transactions between the equipment operations and Financial Services have been eliminated to arrive at the consolidated financial statements.

DEERE & COMPANY

(4) SUPPLEMENTAL CONSOLIDATING DATA

STATEMENTS OF INCOME

For the Three Months Ended August 2, 2026 and July 27, 2025

(In millions of dollars) Unaudited

EQUIPMENT

FINANCIAL

OPERATIONS

SERVICES

ELIMINATIONS

CONSOLIDATED

2026

2025

2026

2025

2026

2025

2026

2025

Net Sales and Revenues

Net sales

$

10,999

$

10,357

$

10,999

$

10,357

Finance and interest income

149

133

$

1,383

$

1,433

$

(179)

$

(140)

1,353

1,426

1

Other income

191

190

122

111

(57)

(66)

256

235

2, 3, 4

Total

11,339

10,680

1,505

1,544

(236)

(206)

12,608

12,018

Costs and Expenses

Cost of sales

7,950

7,578

(11)

(8)

7,939

7,570

4

Research and development expenses

567

556

567

556

Selling, administrative and general expenses

988

999

234

220

(2)

(2)

1,220

1,217

4

Interest expense

99

102

661

720

(50)

(28)

710

794

1

Interest compensation to Financial Services

129

112

(129)

(112)

1

Other operating expenses

(23)

(8)

357

345

(44)

(56)

290

281

3, 4, 5

Total

9,710

9,339

1,252

1,285

(236)

(206)

10,726

10,418

Income before Income Taxes

1,629

1,341

253

259

1,882

1,600

Provision for income taxes

472

274

57

65

529

339

Income after Income Taxes

1,157

1,067

196

194

1,353

1,261

Equity in income (loss) of unconsolidated affiliates

1

(1)

23

11

24

10

Net Income

1,158

1,066

219

205

1,377

1,271

Less: Net loss attributable to noncontrolling interests

(2)

(18)

(2)

(18)

Net Income Attributable to Deere & Company

$

1,160

$

1,084

$

219

$

205

$

1,379

$

1,289

1

Elimination of intercompany interest income and expense.

2

Elimination of equipment operations' margin from inventory transferred to equipment on operating leases.

3

Elimination of income and expenses between equipment operations and Financial Services related to intercompany guarantees of investments in certain international markets.

4

Elimination of intercompany service revenues and fees.

5

Elimination of Financial Services' lease depreciation expense related to inventory transferred to equipment on operating leases.

DEERE & COMPANY

SUPPLEMENTAL CONSOLIDATING DATA (Continued)

STATEMENTS OF INCOME

For the Nine Months Ended August 2, 2026 and July 27, 2025

(In millions of dollars) Unaudited

EQUIPMENT

FINANCIAL

OPERATIONS

SERVICES

ELIMINATIONS

CONSOLIDATED

2026

2025

2026

2025

2026

2025

2026

2025

Net Sales and Revenues

Net sales

$

30,779

$

28,338

$

30,779

$

28,338

Finance and interest income

379

351

$

4,093

$

4,268

$

(461)

$

(386)

4,011

4,233

1

Other income

616

580

408

350

(225)

(211)

799

719

2, 3, 4

Total

31,774

29,269

4,501

4,618

(686)

(597)

35,589

33,290

Costs and Expenses

Cost of sales

22,518

20,239

(32)

(24)

22,486

20,215

4

Research and development expenses

1,704

1,631

1,704

1,631

Selling, administrative and general expenses

2,775

2,761

632

632

(6)

(6)

3,401

3,387

4

Interest expense

294

282

1,973

2,206

(126)

(80)

2,141

2,408

1

Interest compensation to Financial Services

334

306

(334)

(306)

1

Other operating expenses

(59)

(47)

1,093

1,045

(188)

(181)

846

817

3, 4, 5

Total

27,566

25,172

3,698

3,883

(686)

(597)

30,578

28,458

Income before Income Taxes

4,208

4,097

803

735

5,011

4,832

Provision for income taxes

1,059

752

184

153

1,243

905

Income after Income Taxes

3,149

3,345

619

582

3,768

3,927

Equity in income (loss) of unconsolidated affiliates

(4)

34

15

34

11

Net Income

3,149

3,341

653

597

3,802

3,938

Less: Net loss attributable to noncontrolling interests

(6)

(24)

(6)

(24)

Net Income Attributable to Deere & Company

$

3,155

$

3,365

$

653

$

597

$

3,808

$

3,962

1

Elimination of intercompany interest income and expense.

2

Elimination of equipment operations' margin from inventory transferred to equipment on operating leases.

3

Elimination of income and expenses between equipment operations and Financial Services related to intercompany guarantees of investments in certain international markets.

4

Elimination of intercompany service revenues and fees.

5

Elimination of Financial Services' lease depreciation expense related to inventory transferred to equipment on operating leases.

DEERE & COMPANY

SUPPLEMENTAL CONSOLIDATING DATA (Continued)

CONDENSED BALANCE SHEETS

(In millions of dollars) Unaudited

EQUIPMENT

FINANCIAL

OPERATIONS

SERVICES

ELIMINATIONS

CONSOLIDATED

Aug 2

Nov 2

Jul 27

Aug 2

Nov 2

Jul 27

Aug 2

Nov 2

Jul 27

Aug 2

Nov 2

Jul 27

2026

2025

2025

2026

2025

2025

2026

2025

2025

2026

2025

2025

Assets

Cash and cash equivalents

$

6,607

$

6,340

$

6,641

$

2,321

$

1,936

$

1,939

$

8,928

$

8,276

$

8,580

Marketable securities

155

217

240

1,195

1,194

1,167

1,350

1,411

1,407

Receivables from Financial Services

5,364

4,649

3,649

$

(5,364)

$

(4,649)

$

(3,649)

6

Trade accounts and notes receivable – net

1,472

1,316

1,335

8,442

5,900

7,064

(2,191)

(1,899)

(2,296)

7,723

5,317

6,103

7

Financing receivables – net

106

88

84

42,754

44,487

43,846

42,860

44,575

43,930

Financing receivables securitized – net

2

1

1

6,314

6,830

7,947

6,316

6,831

7,948

Other receivables

1,926

1,809

2,013

594

658

867

(54)

(64)

(54)

2,466

2,403

2,826

8

Equipment on operating leases – net

7,400

7,600

7,512

7,400

7,600

7,512

Inventories

7,811

7,406

7,713

7,811

7,406

7,713

Property and equipment – net

7,975

8,047

7,680

31

32

33

8,006

8,079

7,713

Goodwill

4,466

4,188

4,209

4,466

4,188

4,209

Other intangible assets – net

940

892

926

940

892

926

Retirement benefits

3,439

3,181

3,092

104

94

92

(2)

(2)

(2)

3,541

3,273

3,182

Deferred income taxes

2,487

2,507

2,471

47

46

44

(191)

(269)

(306)

2,343

2,284

2,209

9

Other assets

2,371

2,218

2,357

1,098

1,244

1,211

(12)

(1)

(9)

3,457

3,461

3,559

Total Assets 

$

45,121

$

42,859

$

42,411

$

70,300

$

70,021

$

71,722

$

(7,814)

$

(6,884)

$

(6,316)

$

107,607

$

105,996

$

107,817

Liabilities and Stockholders' Equity

Liabilities

Short-term borrowings

$

417

$

414

$

461

$

16,698

$

13,382

$

14,146

$

17,115

$

13,796

$

14,607

Short-term securitization borrowings

1

1

6,094

6,595

7,610

6,095

6,596

7,610

Payables to equipment operations

5,364

4,649

3,649

$

(5,364)

$

(4,649)

$

(3,649)

6

Accounts payable and accrued expenses

12,796

12,757

12,795

3,129

3,116

3,146

(2,257)

(1,964)

(2,359)

13,668

13,909

13,582

7, 8

Deferred income taxes

326

347

393

276

356

402

(191)

(269)

(306)

411

434

489

9

Long-term borrowings

8,907

8,756

8,789

31,719

34,788

35,640

40,626

43,544

44,429

Retirement benefits and other liabilities

1,586

1,646

1,767

67

66

71

(2)

(2)

(2)

1,651

1,710

1,836

Total liabilities

24,033

23,921

24,205

63,347

62,952

64,664

(7,814)

(6,884)

(6,316)

79,566

79,989

82,553

Redeemable noncontrolling interest

44

51

84

44

51

84

Stockholders' Equity

Total Deere & Company stockholders' equity

27,990

25,950

25,175

6,953

7,069

7,058

(6,953)

(7,069)

(7,058)

27,990

25,950

25,175

10

Noncontrolling interests

7

6

5

7

6

5

Financial Services' equity

(6,953)

(7,069)

(7,058)

6,953

7,069

7,058

10

Adjusted total stockholders' equity

21,044

18,887

18,122

6,953

7,069

7,058

27,997

25,956

25,180

Total Liabilities and Stockholders' Equity 

$

45,121

$

42,859

$

42,411

$

70,300

$

70,021

$

71,722

$

(7,814)

$

(6,884)

$

(6,316)

$

107,607

$

105,996

$

107,817

6

Elimination of receivables / payables between equipment operations and Financial Services.

7

Primarily reclassification of sales incentive accruals on receivables sold to Financial Services.

8

Reclassification of other receivables / payables.

9

Reclassification of deferred tax assets / liabilities in the same taxing jurisdictions.

10

Elimination of Financial Services' equity.

DEERE & COMPANY

SUPPLEMENTAL CONSOLIDATING DATA (Continued)

STATEMENTS OF CASH FLOWS

For the Nine Months Ended August 2, 2026 and July 27, 2025

(In millions of dollars) Unaudited

EQUIPMENT

FINANCIAL

OPERATIONS

SERVICES

ELIMINATIONS

CONSOLIDATED

2026

2025

2026

2025

2026

2025

2026

2025

Cash Flows from Operating Activities

Net income

$

3,149

$

3,341

$

653

$

597

$

3,802

$

3,938

Adjustments to reconcile net income to net cash provided by
 operating activities:

Provision (credit) for credit losses

(1)

18

206

240

205

258

Depreciation and amortization

1,042

965

821

804

$

(76)

$

(101)

1,787

1,668

11

Impairments and other adjustments

61

(32)

29

Share-based compensation expense

116

104

116

104

12

Distributed earnings of Financial Services

794

1,066

(794)

(1,066)

13

Provision (credit) for deferred income taxes

20

(242)

(81)

140

(61)

(102)

Changes in assets and liabilities:

Receivables related to sales

(123)

(66)

(1,129)

(428)

(1,252)

(494)

14, 16

Inventories

(330)

(423)

(113)

(103)

(443)

(526)

15

Accounts payable and accrued expenses

61

(646)

(34)

69

(293)

(140)

(266)

(717)

16

Accrued income taxes payable/receivable

(99)

(89)

(20)

(58)

(119)

(147)

Retirement benefits

(359)

(770)

(8)

(43)

(367)

(813)

Other

(142)

123

71

182

(81)

(39)

(152)

266

11, 12, 15

Net cash provided by operating activities

4,012

3,338

1,608

1,899

(2,370)

(1,773)

3,250

3,464

Cash Flows from Investing Activities

Collections of receivables (excluding receivables related
  to sales)

20,261

20,178

(339)

(466)

19,922

19,712

14

Proceeds from maturities and sales of marketable securities

108

27

281

332

389

359

Proceeds from sales of equipment on operating leases

1,479

1,408

1,479

1,408

Cost of receivables acquired (excluding receivables
  related to sales)

(19,351)

(19,189)

212

227

(19,139)

(18,962)

14

Acquisitions of businesses, net of cash acquired

(455)

(89)

(455)

(89)

Purchases of marketable securities

(42)

(133)

(319)

(465)

(361)

(598)

Purchases of property and equipment

(714)

(851)

(2)

(1)

(716)

(852)

Cost of equipment on operating leases acquired

(2,086)

(2,148)

153

139

(1,933)

(2,009)

15

Increase in investment in Financial Services

(5)

5

17

Increase in trade and wholesale receivables

(1,550)

(807)

1,550

807

14

Collections of receivables from unconsolidated affiliates

189

197

145

197

334

Collateral on derivatives – net

1

4

(64)

123

(63)

127

Other

(72)

(75)

(73)

(156)

(145)

(231)

Net cash used for investing activities

(1,179)

(928)

(1,227)

(580)

1,581

707

(825)

(801)

Cash Flows from Financing Activities

Net proceeds (payments) in short-term borrowings (original
  maturities three months or less)

18

294

3,187

(2,354)

3,205

(2,060)

Change in intercompany receivables/payables

(735)

(660)

735

660

Proceeds from borrowings issued (original maturities greater
  than three months)

430

2,188

4,943

8,519

5,373

10,707

Payments of borrowings (original maturities greater than
  three months)

(262)

(863)

(8,076)

(6,880)

(8,338)

(7,743)

Repurchases of common stock

(697)

(1,136)

(697)

(1,136)

Capital investment from Equipment Operations

5

(5)

17

Dividends paid

(1,316)

(1,282)

(794)

(1,066)

794

1,066

(1,316)

(1,282)

13

Other

(27)

(25)

(28)

(18)

(55)

(43)

Net cash used for financing activities

(2,589)

(1,484)

(28)

(1,139)

789

1,066

(1,828)

(1,557)

Effect of Exchange Rate Changes on Cash, Cash
 Equivalents, and Restricted Cash

22

96

(2)

12

20

108

Net Increase in Cash, Cash Equivalents, and Restricted Cash

266

1,022

351

192

617

1,214

Cash, Cash Equivalents, and Restricted Cash at
 Beginning of Period

6,364

5,643

2,169

1,990

8,533

7,633

Cash, Cash Equivalents, and Restricted Cash at
 End of Period

$

6,630

$

6,665

$

2,520

$

2,182

$

9,150

$

8,847

11

Elimination of depreciation on leases related to inventory transferred to equipment on operating leases.

12

Reclassification of share-based compensation expense.

13

Elimination of dividends from Financial Services to the equipment operations, which are included in the equipment operations operating activities.

14

 Primarily reclassification of receivables related to the sale of equipment.

15

Reclassification of direct lease agreements with retail customers.

16

Reclassification of sales incentive accruals on receivables sold to Financial Services.

17

Elimination of change in investment from equipment operations to Financial Services.

SOURCE Deere & Company

Ballentine Partners LLC raised its position in shares of Micron Technology, Inc. (NASDAQ:MU – Free Report) by 2.9% in the second quarter, according to its most recent filing with the SEC. The firm owned 63,727 shares of the semiconductor manufacturer’s stock after purchasing an additional 1,766 shares during the quarter. Micron Technology makes up approximately 0.9% of Ballentine Partners LLC’s investment portfolio, making the stock its 14th largest holding. Ballentine Partners LLC’s holdings in Micron Technology were worth $73,559,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in shares of Micron Technology by 1.9% in the 4th quarter. Vanguard Group Inc. now owns 106,608,094 shares of the semiconductor manufacturer’s stock valued at $30,427,016,000 after acquiring an additional 1,954,644 shares in the last quarter. State Street Corp lifted its position in Micron Technology by 2.1% in the 4th quarter. State Street Corp now owns 52,749,817 shares of the semiconductor manufacturer’s stock valued at $15,061,310,000 after acquiring an additional 1,090,644 shares in the last quarter. Norges Bank bought a new position in shares of Micron Technology in the fourth quarter valued at approximately $6,433,456,000. Morgan Stanley boosted its holdings in Micron Technology by 5.1% during the 4th quarter. Morgan Stanley now owns 16,396,655 shares of the semiconductor manufacturer’s stock worth $4,679,771,000 after acquiring an additional 794,289 shares during the last quarter. Finally, Northern Trust Corp boosted its holdings in Micron Technology by 1.9% during the fourth quarter. Northern Trust Corp now owns 10,654,349 shares of the semiconductor manufacturer’s stock worth $3,040,858,000 after purchasing an additional 194,550 shares during the last quarter. 80.84% of the stock is owned by institutional investors.

Analyst Ratings Changes Several research analysts have weighed in on the company. Rosenblatt Securities boosted their price objective on Micron Technology from $1,200.00 to $1,500.00 and gave the stock a “buy” rating in a research report on Thursday, June 25th. Wolfe Research set a $1,500.00 price objective on shares of Micron Technology in a research note on Thursday, June 25th. Mizuho lifted their target price on Micron Technology from $1,150.00 to $1,375.00 and gave the company an “outperform” rating in a report on Thursday, June 25th. The Goldman Sachs Group upped their price target on shares of Micron Technology from $900.00 to $1,100.00 and gave the stock a “neutral” rating in a report on Thursday, June 25th. Finally, ThinkEquity restated a “buy” rating on shares of Micron Technology in a research report on Monday, August 3rd. Three equities research analysts have rated the stock with a Strong Buy rating, thirty-two have given a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Micron Technology currently has an average rating of “Buy” and an average target price of $1,259.97.

View Our Latest Research Report on Micron Technology Micron Technology Trading Down 0.4% NASDAQ:MU opened at $937.10 on Thursday. The company has a quick ratio of 2.98, a current ratio of 3.42 and a debt-to-equity ratio of 0.05. The company has a fifty day moving average of $967.75 and a 200 day moving average of $690.43. The firm has a market capitalization of $1.06 trillion, a P/E ratio of 21.22 and a beta of 2.18. Micron Technology, Inc. has a 52 week low of $113.46 and a 52 week high of $1,255.00.

Micron Technology (NASDAQ:MU – Get Free Report) last announced its quarterly earnings results on Wednesday, June 24th. The semiconductor manufacturer reported $25.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $21.39 by $3.72. Micron Technology had a return on equity of 71.13% and a net margin of 55.91%.The company had revenue of $41.46 billion for the quarter, compared to the consensus estimate of $35.91 billion. During the same quarter in the previous year, the business earned $1.91 EPS. Micron Technology’s revenue was up 345.8% compared to the same quarter last year. Micron Technology has set its Q4 2026 guidance at 30.000-32.000 EPS. On average, research analysts predict that Micron Technology, Inc. will post 72.93 earnings per share for the current year.

Micron Technology Dividend Announcement The company also recently declared a quarterly dividend, which was paid on Tuesday, July 21st. Investors of record on Monday, July 6th were given a dividend of $0.15 per share. The ex-dividend date was Monday, July 6th. This represents a $0.60 annualized dividend and a dividend yield of 0.1%. Micron Technology’s payout ratio is currently 1.36%.

Insider Buying and Selling at Micron Technology In other news, Director Lynn A. Dugle sold 1,300 shares of the company’s stock in a transaction dated Tuesday, June 30th. The shares were sold at an average price of $1,150.43, for a total value of $1,495,559.00. Following the sale, the director directly owned 17,728 shares of the company’s stock, valued at $20,394,823.04. This represents a 6.83% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Sanjay Mehrotra sold 31,285 shares of the firm’s stock in a transaction that occurred on Friday, July 24th. The shares were sold at an average price of $926.83, for a total transaction of $28,995,876.55. Following the transaction, the chief executive officer directly owned 313,218 shares of the company’s stock, valued at $290,299,838.94. This represents a 9.08% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 162,179 shares of company stock worth $167,811,861. Corporate insiders own 0.24% of the company’s stock.

Trending Headlines about Micron Technology Here are the key news stories impacting Micron Technology this week:

Positive Sentiment: Micron is benefiting from accelerating artificial-intelligence demand for high-bandwidth memory (HBM), server DRAM and data-center storage. The expansion of agentic AI workloads could broaden the company’s memory opportunity and support long-term growth. Will Agentic AI Adoption Expand Micron’s Memory Growth Opportunity? Positive Sentiment: Micron continues to gain NAND market share, while its SSD business surpassed $5 billion in quarterly revenue and NAND revenue reportedly grew sharply year over year. Long-term customer agreements also provide visibility into demand through 2028. Micron Stock Is Under Pressure but the Market Is Missing the Good News Positive Sentiment: SK Hynix’s authorization of an approximately $28.6 billion share-repurchase and cancellation program is lifting sentiment across the memory sector. The move signals management confidence in AI-memory demand and helped Micron rebound earlier in the session. SK Hynix Rises on Buyback as Memory Names Rebound Positive Sentiment: Analysts remain constructive: Bank of America reiterated a Buy rating and a $1,550 price target, while other commentary highlights Micron’s comparatively low forward valuation despite its AI-driven earnings growth. Analyst Issues New Micron Stock Price Target Neutral Sentiment: Micron’s latest reported quarter substantially exceeded expectations, with revenue of $41.46 billion versus a $35.91 billion consensus estimate and EPS of $25.11 versus $21.39 expected. However, investors are now focusing more on the durability of these unusually strong results than on the earnings beat itself. Negative Sentiment: Rising Treasury yields and concerns about higher financing costs for AI infrastructure are pressuring high-growth semiconductor stocks. The weakness has spread across global memory names and reflects profit-taking after Micron’s substantial year-to-date rally. AI Chip Stocks Pull Back as Yields Rise Negative Sentiment: Some investors question whether HBM pricing and demand can remain elevated as memory remains a cyclical industry. Concerns about aggressive semiconductor capacity expansion, concentrated hyperscaler spending and Micron trading well above estimated intrinsic value are adding valuation risk. Micron Trades Above GF Value as Semiconductor Selloff Deepens Micron Technology Company Profile (Free Report)

Micron Technology, Inc is a global semiconductor company that designs and manufactures memory and storage solutions. Its product portfolio includes dynamic random-access memory (DRAM), NAND flash memory, solid-state drives (SSDs), memory modules and embedded memory solutions for a wide range of computing and electronic devices. Micron supplies components used in data centers, enterprise and cloud infrastructure, client computing, mobile devices, automotive systems and industrial applications, and also markets consumer-facing products under the Crucial brand.

Founded in 1978 and headquartered in Boise, Idaho, Micron has grown into an international manufacturer with research, development and production facilities across multiple regions.

Further Reading Five stocks we like better than Micron Technology Bloom Energy’s AI Surge Meets a Valuation Reality Check Target Is Winning Shoppers Back—Can the Rally Reach $180? IonQ’s Space Contract Points to a New Frontier for Quantum Investors Is Apple’s AI Strategy Smarter Than Skeptics Think?

Receive News & Ratings for Micron Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Micron Technology and related companies with MarketBeat.com's FREE daily email newsletter.

watch now

Dave Petso has been a wealth manager in Boise, Idaho since the 1980s. His business has survived multiple recessions, the bursting of the dot-com bubble and the 2008 financial crisis.

For most of Petso's 45-year career, Micron, the hometown maker of computer memory, has been a boring enterprise tech company and, in his words, a "terrible investment."

But almost four years into the artificial intelligence craze, the sleepy semiconductor company is one of the hottest names on the planet, turning many of Petso's clients into sudden millionaires. A big part of Petso's job has become helping Micron employees diversify after a more than tenfold increase in the stock since the end of 2024 lifted the company's market cap past $1 trillion.

"You've got a boatload of money now, and it's all tied up in one company," Petso said in an interview. Where clients had been figuring out what to do with some $20,000 worth of stock, "now we're talking about hundreds of thousands or millions of dollars," he said. 

Micron vs. S&P 500 over past five years

Across Boise, a Mountain West city of about 250,000 residents that's best known for outdoor adventures and the blue turf football field at Boise State University, the Micron boom is showing up in the form of job growth, new construction projects, a bustling dining scene and an influx in new residents.

Micron has broken ground on two new chip manufacturing facilities that are expected to create more than 17,000 new jobs in the area. That includes 3,500 at Micron, which currently employs about 7,000 people in and around Boise. 

With the city's rapid expansion comes plenty of annoyances. Residents complain of frequent traffic jams around town or on Interstate 84, rising housing costs and a rush of people from California and elsewhere altering the local culture and landscape. Average rental prices in Boise have climbed 4.3% in the past year, while average prices nationwide have dropped, according to Zillow.

"One of Boise's competitive advantages was our low cost of living," said Jason Crawforth, a lifelong resident of Boise who's been building tech companies in the area for almost 35 years. But Crawforth said that while he's seeing his net worth go up from an investment in Micron, "there's a large demographic of our community that doesn't have a direct benefit from that." 

CNBC spoke to residents, business owners, real estate agents and others in the Boise area about the recent boom, its impact on the city and what could still be coming as Micron embarks on a $50 billion expansion plan. They collectively portray the city as an unexpected winner in the global AI buildout, one that's trying to hang onto its identity while not becoming overreliant on a technology with a long history of boom-and-bust cycles.  

While the trajectory still points up and to the right, Micron shares plunged 29% in July, their worst month since 2002. Shareholders hope it was just a corrective blip, and not a sign of things to come. The stock is up 14% so far in August.

Boise and the global memory raceMicron was founded in Boise nearly 50 years ago in the basement of a dental office. By 1981 its first chip fabrication plant was up and running there, pumping out general-purpose memory chips known as DRAM. In its latest quarter, DRAM accounted for 76% of Micron's total revenue.

DRAM is also the type of chips that are stacked to make high-bandwidth memory, or HBM, which is then added to the powerful processors used for AI.

As HBM gobbles up the world's supply of DRAM, it's caused a global shortage and skyrocketing memory costs, leading to higher prices across the board, even for consumer electronics like Apple's MacBooks and iPads.

All three of the world's top HBM suppliers — market leader SK Hynix, Samsung and Micron — are building huge new plants to try and meet demand. SK Hynix and Samsung are constructing mega-fabs in their home country of South Korea.

They've all been handsomely rewarded by the stock market despite the July pullback. Micron leads the pack, up almost 670% in the past year, followed by SK Hynix at about 470% and Samsung at over 250%. 

The rally turned Micron CEO Sanjay Mehrotra, a nine-year veteran of the company, into a billionaire earlier this year, though last month's selloff pushed him below that mark. 

For Mehrotra, Boise represents a big opportunity to help turn his company into a hotbed for U.S. manufacturing. The first of Micron's two new Boise fabs is scheduled to come online in 2027. It will be the country's first front-end factory for manufacturing leading-edge memory. Most of Micron's top-end memory is currently produced in Taiwan, Japan and Singapore. 

The site also includes utility and water-treatment buildings to support the resource-intensive process of making chips. Local utility Idaho Power told CNBC in a statement that it "does not expect large-load growth, including Micron's expansion, to increase electric bills for other customers."

Additional AI-driven growth in the area is coming from Meta, which is building an $800 million data center 20 miles southwest, in Kuna, Idaho, that it says will create about 100 operational jobs. There's a flurry of new offices from Micron suppliers like Lam Research and cleanroom builder Exyte, plus contractors coming in for lucrative jobs helping to build Micron's fabs.

With Boise, and an even bigger memory fab campus coming to Clay, New York, Micron's long-term goal is to produce 40% of its DRAM in the U.S. It plans to spend $250 billion through 2035 to get there, with the help of up to $6.2 billion of CHIPS Act funds, which were granted under the Biden administration. 

Micron is part of the fabric of Boise's economy, alongside other local legends like the Albertsons grocery chain and the potato empire of J.R. Simplot, who was one of Micron's first investors.

Today, the memory maker is among Ada County's leading employers, after Boise State and the region's health system. 

"It's always been something that we've been around, but of course recently, with Boise, Idaho being a very small market, it's probably one of our largest success stories that we've ever had," said JT Belnap, founder of Treasure Valley Financial Planning, which is now almost exclusively focused on managing Micron employees' wealth. 

Belnap told CNBC that his firm's phones are "continuing to ring" with requests from Micron employees who are close to retirement. 

Because of the stock appreciation, some are moving up their timelines to exit the workforce from three or four years to one or two, Belnap said. To take advantage of tax benefits, others are donating stock to charities. And plenty are taking some profit for a dream purchase, like one of Belnap's clients who recently bought an $80,000 truck he'd always wanted. 

"What I've learned doing financial planning for as long as I have is when anyone comes into some real wealth that's kind of a sudden thing, you need to allow them to have a little bit of fun," Belnap said. 

Selling stock to buy jewelry, homesAbout 9 miles east of Belnap's office, a very different kind of business is noticing a similar trend. Lisa Zimowsky, owner of jewelry boutique The Diamond Girls, said her sales are up 60% for the year. 

"I do know of several people that have sold some stock and bought with us," Zimowsky said. "Usually it's the people that got a quarterly bonus when the stock was $150," or less than one-sixth its current price. 

"The Boise economy is super strong," Zimowsky added. "I think Micron's been a big part of that."

Then there's the real estate market. 

Sheila Smith, an agent in the area, said she's seen more prospective buyers and fewer listings for homes in the southeast part of the city, near Micron's headquarters. Smith said there's so much construction that some Micron contractors involved with the new fabs are purchasing homes.

"Typically if somebody knows they're only going to be here temporarily, for an interim-type job, such as the engineers, they don't look to buy," Smith said in an interview. "They are coming here and they are buying."

Mortgage broker Gerald Robinson said that over about a month-long stretch, he consulted with four Micron clients who were looking to buy homes. 

"We're seeing a lot of stock options being executed right now, and people [are] purchasing," said Robinson, CEO of 1st Choice Mortgage.

One of the two clients who ended up buying a house did so as an investment to run an Airbnb-style property, Robinson said. The other was a first-time homebuyer in her early 20s.

Two of the prospects didn't end up needing Robinson's help, as they opted to sell stock and buy properties in cash, Robinson said. 

Micron told CNBC that stock offerings are a key part of the company's strategy to recruit and retain talent. Through the first three quarters of this fiscal year, Micron had recorded $954 million in stock-based compensation, up more than 100% from three years ago. 

"We do lean into stock awards very heavily," said April Arnzen, Micron's chief people officer and an Idaho native who's worked at the company for 27 years. "We want our team members to be owners in the company and share in the success of the company."

It's not just employees who have gotten in on the action. 

As a longtime part of the Boise tech community, Crawforth bought Micron shares when they traded around $16 each, and said he still owns north of 1,500 to this day. That's a stake worth over $1.4 million. 

But the growth led to an accidental imbalance in the family. 

"I made a mistake – I bought some for my niece, but not for my nephew," Crawforth said. "All of a sudden, my niece's investment to help her put a down payment on a house when she's old enough is significantly higher than my nephew." 

Crawforth said he's got a "moral dilemma" as he figures out "how to rectify that situation."

His partner also bought, but at a higher price, and was able to pay off a portion of car debt after recently cashing in her position at around $1,200 a share.

A city's new chapter With so much new wealth and with demand rising for homes, concerns are spreading that Boise is becoming unaffordable for those not boosted by the Micron effect. Median home sale prices in Boise are up 2.9% over the past year as of June, compared to a 1.2% average increase nationwide, according to Redfin. 

"Now we're just seeing the lower incomes maybe getting a little bit more and more priced out, because wages may not be keeping up with home prices," Robinson said. 

Ada County has swelled by around 19% since 2020, adding close to 95,000 people, according to estimates from Compass Idaho. Statewide, Idaho's growth is the fastest in the nation over a similar period. People have flocked there from California, Washington and Oregon, taking advantage of Boise's lower cost of living, relatively mild winters, and lively outdoor scene. 

The demographics are noticeably changing, Zimowsky said. 

"Five years ago, nobody had a designer purse here, nobody cared, nobody even knew what Louis Vuitton was," she said. "Now everybody's carrying them."

For food lovers and concert goers, Boise's growth has taken the city up a notch. Boise State's Albertsons Stadium, home to the iconic blue turf, hosted performances from Post Malone and Jelly Roll last year, while Jason Aldean and the Alabama Shakes came through town more recently. 

"The amenities here have changed a lot," said Clark Krause, executive director of the Boise Valley Economic Partnership. Residents now have "access to things that someone living in a city would enjoy."

Long before he became the first Idaho chef to win a James Beard award, Kris Komori decided Boise was where he wanted to raise his growing family. When he moved to Boise from Portland, Oregon, in 2013, there weren't very many hotels and high-rise buildings dotting the landscape, and the dining scene was much quieter. 

"Everyone was like, 'What are you going to do out in Idaho?'" said Komori, the co-owner and executive chef at KIN Boise, which is located downtown. Now, "you can't go a block without there being some sort of construction going on."

KIN Boise, where a seasonal prix fixe meal runs $130 per person, is one of the top dining destinations in town, and a hot spot for Micron employees, especially when they're taking out clients, Komori said. 

"They just frequent us much more now," Komori said. "That's a compliment to us because they want to kind of show off Boise, and we're on the list for that."

Komori said that every month, more restaurants − small businesses and chains alike − are opening downtown, and he's increasingly seeing more outside the city center. 

Scaling challengesPetso, who moved to Boise in 1980 when the city had about one-third its current population, said he appreciates the vibrancy despite some of the drawbacks. 

"It's so expensive to go out to dinner, but they're all packed," Petso said, of the restaurants. "You just walk downtown in Boise and just go, 'This is amazing.'"

Micron is well aware of the pressure created by such rapid expansion, which will only intensify with the thousands of new people the company is still planning to hire. 

"When you're scaling that many people in a short amount of time, there certainly are challenges such as transportation, such as housing," Arnzen said. She added that the company has been partnering with the state and county and at the "local level on solutions to make sure we're staying a step ahead." 

Arnzen said the company has made commitments around housing and is looking at "a lot of different roadway investment opportunities." The company also built a childcare center for employees in partnership with the YMCA, and is planning to spend $75 million on workforce, education and community development across the state over the next decade. 

Additionally, Micron has a chip camp for middle school students, a Micron-sponsored training fab at Boise State, and an apprenticeship program at the College of Western Idaho in nearby Nampa.

"There are at least five buildings with the Micron name on those two campuses," Arnzen said. "Micron has been investing in those education institutions for years, and of course we're not going to stop. We need more talent."

Beyond the sprawl of cranes, bumper-to-bumper traffic on I-84 and Micron's community initiatives, there's growing concern about the sustainability of the memory boom. 

Read more CNBC tech newsMarvell pops on AI chip deal that lets Google buy up to $12.2 billion in sharesNvidia plays matchmaker in Nordics, sources tell CNBC, as AI data center deals boom in regionThe U.S. banned Nvidia's best chips from going to China. Now it's trying to close a crucial loopholeAmazon to expand drone service to nearly 500 cities after targeting 1 million deliveries this yearCrawforth got a taste of the risk when the stock unwound in July.

"That's probably 600 grand for me personally in net worth that I've seen go away," Crawforth said, speaking of last month's stock drop. He was quick to note that over a three-month stretch it was up 50%, so "it's still a win." 

For Petso, the moment has clear parallels to the last time Micron millionaires were showing up at his office. It was the dot-com bubble of 1999, and tech mania was everywhere. Micron shares jumped more than 50% that year after almost doubling the year prior. 

Some of Petso's clients refused to sell even a portion of their holdings. The stock lost three-quarters of its value over the next three years, a crash that Petso said left "deep scars" for everyone involved.

It was a painful lesson, and one that he'd rather not have his existing client base learn the hard way.

"Trying to get people to trim and get out is really the discussions we're having now," Petso said. "You guys are killing it out there, but I've been around a long time. You were killing it in 1999 too."

watch now

BlackRock Inc. increased its holdings in Union Pacific Corporation (NYSE:UNP – Free Report) by 0.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 47,894,147 shares of the railroad operator’s stock after purchasing an additional 115,607 shares during the quarter. BlackRock Inc. owned approximately 8.06% of Union Pacific worth $13,027,208,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of the business. Rachor Investment Advisory Services LLC purchased a new stake in Union Pacific in the 4th quarter worth approximately $25,000. Tucker Asset Management LLC purchased a new position in shares of Union Pacific during the fourth quarter valued at approximately $25,000. SWAN Capital LLC raised its holdings in shares of Union Pacific by 2,575.0% during the fourth quarter. SWAN Capital LLC now owns 107 shares of the railroad operator’s stock valued at $25,000 after acquiring an additional 103 shares in the last quarter. High Point Wealth Management LLC bought a new position in shares of Union Pacific during the fourth quarter valued at approximately $26,000. Finally, Cornerstone Financial Management LLC purchased a new stake in Union Pacific in the fourth quarter worth $27,000. Hedge funds and other institutional investors own 80.38% of the company’s stock.

Union Pacific Stock Performance Shares of UNP stock opened at $301.69 on Thursday. Union Pacific Corporation has a 12 month low of $210.84 and a 12 month high of $315.99. The stock has a market cap of $179.23 billion, a PE ratio of 24.43, a price-to-earnings-growth ratio of 3.05 and a beta of 0.96. The company has a current ratio of 0.99, a quick ratio of 0.82 and a debt-to-equity ratio of 1.40. The company’s fifty day moving average price is $284.87 and its 200-day moving average price is $266.83.

Union Pacific (NYSE:UNP – Get Free Report) last issued its quarterly earnings results on Thursday, July 23rd. The railroad operator reported $3.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.26 by $0.15. The company had revenue of $6.86 billion during the quarter, compared to analyst estimates of $6.72 billion. Union Pacific had a net margin of 28.85% and a return on equity of 38.46%. Union Pacific’s quarterly revenue was up 11.5% compared to the same quarter last year. During the same period last year, the business earned $3.03 EPS. On average, equities analysts expect that Union Pacific Corporation will post 12.93 EPS for the current fiscal year. Union Pacific Increases Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Monday, August 31st will be issued a $1.42 dividend. This represents a $5.68 dividend on an annualized basis and a yield of 1.9%. This is a boost from Union Pacific’s previous quarterly dividend of $1.38. The ex-dividend date is Monday, August 31st. Union Pacific’s dividend payout ratio is currently 44.70%.

Insiders Place Their Bets In other Union Pacific news, EVP Eric J. Gehringer sold 2,991 shares of the company’s stock in a transaction dated Wednesday, June 3rd. The shares were sold at an average price of $263.96, for a total value of $789,504.36. Following the sale, the executive vice president owned 43,012 shares in the company, valued at approximately $11,353,447.52. This represents a 6.50% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.22% of the company’s stock.

Wall Street Analyst Weigh In Several analysts recently weighed in on the stock. Raymond James Financial reiterated a “strong-buy” rating on shares of Union Pacific in a report on Monday, July 13th. The Goldman Sachs Group set a $317.00 target price on shares of Union Pacific and gave the stock a “neutral” rating in a research report on Thursday, July 23rd. Bank of America lifted their target price on shares of Union Pacific from $301.00 to $334.00 and gave the company a “buy” rating in a research note on Thursday, July 23rd. Royal Bank Of Canada reiterated an “outperform” rating and set a $339.00 price target (up from $289.00) on shares of Union Pacific in a research report on Friday, July 24th. Finally, Barclays reissued an “overweight” rating and issued a $350.00 price target (up from $315.00) on shares of Union Pacific in a research note on Friday, July 24th. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $320.89.

Read Our Latest Stock Analysis on UNP

Union Pacific Profile (Free Report)

Union Pacific Corporation (NYSE: UNP) is one of the largest freight railroad companies in the United States. Its principal operating subsidiary, Union Pacific Railroad, has roots that trace back to the Pacific Railway Act of 1862 and the construction of the first transcontinental rail link completed in 1869. The company is headquartered in Omaha, Nebraska, and operates as a holding company for rail transportation and related services.

Union Pacific’s core business is the movement of freight by rail across an extensive rail network serving the western two‑thirds of the United States.

Featured Articles Five stocks we like better than Union Pacific Bloom Energy’s AI Surge Meets a Valuation Reality Check Target Is Winning Shoppers Back—Can the Rally Reach $180? IonQ’s Space Contract Points to a New Frontier for Quantum Investors Is Apple’s AI Strategy Smarter Than Skeptics Think?

Receive News & Ratings for Union Pacific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Union Pacific and related companies with MarketBeat.com's FREE daily email newsletter.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

When brokerages making money on a strategy start turning clients away, pay attention. That is what just happened with tax-aware long-short accounts, the fastest-growing tax dodge for the very wealthy.

Two Custodians Just Slammed the Brake Per a Bloomberg “Great American Tax Dodge” investigation published August 18, 2026, Charles Schwab (NYSE:SCHW | SCHW Price Prediction) curbed how much of an adviser’s book can sit in these accounts, raised minimums, imposed borrowing and margin limits, and warned it will issue margin calls when accounts breach the new thresholds.

Fidelity moved earlier and harder. The largest US brokerage, with almost $20 trillion under administration, shut its doors to new clients and hiked fees for some existing ones. A spokesperson said “Fidelity chose to restrict access to new clients due to the unprecedented growth of these strategies on our platform.”

Schwab CEO Rick Wurster told Bloomberg the firm still wants to support the strategy and is going to great lengths to make sure advisers understand how complex and risky the accounts can be. On the July earnings call, he described the market as moving “past” the initial surge and into “more of a stable growth environment.”

What a Tax-Aware Long-Short SMA Actually Does The account bets both on and against companies, engineered to create losses alongside long-term gains, so the accumulated losses erase taxes owed on other investments or income. It’s aimed at people facing big capital events like private equity payouts, business sales, or large market gains.

The accounts require relentless daily transactions, heavy borrowing that can trigger margin calls, a large number of shorted stocks, and sometimes complex derivatives. Fidelity and Schwab supply the financing and stock loans that make it work. Schwab’s Jalina Kerr told Bloomberg: “These sophisticated strategies can involve thousands of positions and significant client reporting intricacies.” Clients receive hundreds of pages of tax documents.

Scale and Systemic Risk The strategy sits at the cutting edge of the $1 trillion “tax alpha” universe that helps wealthy people postpone or eliminate capital gains taxes. Schwab’s revenue from the business climbed to roughly $70 million by the second quarter. CFO commentary pegged it at “roughly 1%” of firm revenue, against total Q2 revenue of $7.1 billion.

Quantinno Capital, the shop that brought the first retail-scale tax-aware long-short SMA to Fidelity in October 2021, now has about $60 billion of assets, up from almost nothing five years ago. AQR surpassed $140 billion at the end of March, about $70 billion of it in tax-loss strategies, up from about $3 billion in 2023.

The custodians’ concern: as more money piles in, more of the same stocks get shorted, and a sudden loss could force everyone to unwind at once. If clients can’t post cash, the brokerage covers the shortfall. Former FDIC chair Sheila Bair told Bloomberg: “There’s no other reason to do it than avoid paying taxes. There’s risk for the firms offering this.”

Where the Wealthy Went Next The plumbing rerouted. Wealth managers ran to Schwab when Fidelity pulled back, and when Schwab curbed access, less traditional firms started fielding calls. Goldman Sachs (NYSE:GS) and BNY Pershing have stepped into custody for these accounts, with Goldman citing “longstanding expertise as prime brokers.”

That’s consistent with Goldman’s Q2. Asset and wealth management revenues hit $4.6 billion, up 20% year-over-year, with wealth client assets near $2 trillion and CEO David Solomon saying the firm has “never been better positioned to help founders and executives realize and manage newly created wealth.”

Regulators are watching. At a July gathering in New York, Treasury officials warned that some strategies designed to slash tax bills may be crossing lines “that should not be crossed.” No rule has been issued.

Retail Playbook: Tax Moves You Can Actually Use This SMA isn’t retail. Minimums, margin calls, and short books put it out of reach for most investors. But the underlying tax code is the same. Three legitimate moves for a taxable brokerage:

Harvest losses inside your regular brokerage. Realized losses offset realized gains dollar for dollar, and up to $3,000 of ordinary income each year, with the remainder carried forward. Mind the 30-day wash-sale rule. Prefer ETFs over mutual funds in taxable accounts. The in-kind creation and redemption mechanism lets ETFs shed low-basis lots without pushing capital gains distributions onto your 1099. Use the 0% long-term capital gains bracket in low-income years. Between retirement and RMDs, many households have a window to realize gains at a 0% federal rate. Pair that with step-up in basis at death for lots you never need to sell. That middle item is bigger than it looks. The quiet years between a last paycheck and the first required withdrawal may be the lowest tax rate a household ever sees again, and we sized up how to use that window in a free guide: The Roth Window.

Clients Piled In Anyway One Boston-based adviser to high-net-worth clients told Bloomberg that on hearing the Schwab news, some of his biggest clients feared increasingly draconian restrictions were coming, and their response was to add even more money to their tax-aware accounts at Schwab while they still could. Schwab, meanwhile, recently recruited for a new role leading its long-short SMA program with a salary as high as $269,900.

When two firms whose margin desks profit from a trade start restricting it, and the buyers respond by ordering more, the story stops being about taxes and starts being about crowding. For a retiree, this is a math conversation worth having with a fiduciary advisor or CPA, not a strategy to chase.

Contact [email protected] for any questions or corrections.

Coinbase shares surged 8% in premarket trading Thursday as a sharp rebound in cryptocurrency prices combined with renewed support from the Trump administration for industry regulation.

The move came after President Donald Trump met with senior cryptocurrency executives at the White House, including Coinbase CEO Brian Armstrong, and called on Congress to pass the CLARITY Act.

The rally also followed the US Treasury Department’s decision to expand buyback operations for longer-dated government securities in an attempt to support market liquidity and ease rising borrowing costs.

At the same time, a wave of forced liquidations across the crypto market intensified the rally.

Bitcoin climbed above $70,000 for the first time since early June, while several major altcoins posted even larger gains.

The combination gave crypto-related equities a fresh boost after a period of weakness, with Coinbase emerging as one of the biggest beneficiaries because of its direct exposure to trading activity and digital-asset prices.

Strategy, Bitmine Immersion Technology, Circle all gained.

“The move towards $70,000, triggered by short-covering, suggests buyers are regaining confidence, although the rally now faces a crucial test of whether it can sustain momentum and challenge the $75,000 region,” said Axel Rudolph, chief technical analyst at investing and trading platform IG.

Trump's meeting with crypto executives provided an important policy catalyst for the crypto trade.

The CLARITY Act is designed to establish clearer definitions for digital assets, including determining which tokens should be classified as securities and which should be treated as commodities.

It would also clarify the respective regulatory roles of the Securities and Exchange Commission and the Commodity Futures Trading Commission.

For crypto businesses such as Coinbase, the legislation could reduce one of the industry's biggest challenges: uncertainty over which rules apply to different digital assets.

Trump urged lawmakers to advance what he described as a "fair version of the Clarity Act", as the legislation remains stalled in the Senate with limited time remaining on the congressional calendar.

"Now we need Congress to take the next step by passing the Clarity Act — fair version of the Clarity Act," Trump said in remarks at the event.

Armstrong has separately forecast a bipartisan congressional vote on the legislation on September 15, 2026.

He has suggested that passage could help set the stage for another crypto market rally in October.

Several other industry executives attended the White House event, including Robinhood CEO Vlad Tenev, Kraken co-CEO Arjun Sethi and Intercontinental Exchange CEO Jeffrey Sprecher.

SEC Chair Paul Atkins, CFTC Chair Mike Selig and White House crypto adviser Patrick Witt also participated.

According to CoinGlass data, about $3.3 billion in leveraged cryptocurrency positions were liquidated over a 24-hour period.

Short positions accounted for approximately $3 billion of those liquidations.

Bitcoin and Ethereum accounted for much of the activity, with about $1.15 billion and $1.73 billion of positions liquidated.

The forced unwinding of bearish bets can accelerate price increases because traders whose positions move against them are required to buy assets to close their trades.

Those purchases can push prices higher and trigger further liquidations.

Bitcoin's move above $70,000 therefore became an important psychological milestone for the market, potentially encouraging additional institutional and retail participation.

But Bitcoin was not the strongest performer among major cryptocurrencies.

Ethereum rose nearly 20% over 24 hours to about $2,200, according to CoinGecko.

XRP climbed more than 15%, while Solana gained more than 13%.

The scale of the liquidation event made it the largest of 2026 and the third-largest crypto liquidation event over the past year, according to the data provided.

The White House summit came as US regulators also move toward clearer rules for digital assets.

The SEC on Tuesday proposed long-awaited rules that would exempt certain token offerings from securities regulations, potentially making it easier for crypto companies to issue tokens and raise capital.

The CFTC is also scheduled to discuss cryptocurrency regulation at an industry gathering on Thursday.

That regulatory activity could prove particularly important for Coinbase, which has repeatedly argued that clearer rules would allow crypto companies to operate with greater certainty in the US.

The exchange's fortunes are closely tied to trading activity across the cryptocurrency market, meaning stronger prices and higher transaction volumes can improve investor expectations for its revenue.

However, the CLARITY Act has not yet passed Congress, meaning the regulatory catalyst remains dependent on lawmakers reaching an agreement.

For now, investors are betting on a combination of stronger crypto prices, forced short covering and the possibility of a more supportive regulatory framework.

BlackRock Inc. acquired a new position in HP Inc. (NYSE:HPQ – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 107,463,839 shares of the computer maker’s stock, valued at approximately $2,357,757,000. BlackRock Inc. owned approximately 11.75% of HP as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Pallas Capital Advisors LLC purchased a new stake in shares of HP in the second quarter worth about $380,000. Deutsche Bank AG acquired a new position in HP during the 2nd quarter worth approximately $140,172,000. Commerzbank Aktiengesellschaft FI purchased a new position in HP in the 2nd quarter worth approximately $80,590,000. Trust Co. of Vermont purchased a new position in HP in the 2nd quarter worth approximately $224,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in HP in the second quarter valued at approximately $49,271,000. Institutional investors and hedge funds own 77.53% of the company’s stock.

HP Trading Up 0.1% Shares of HPQ opened at $29.99 on Thursday. HP Inc. has a 52 week low of $17.56 and a 52 week high of $32.19. The firm has a market cap of $27.43 billion, a price-to-earnings ratio of 11.07, a PEG ratio of 5.05 and a beta of 1.17. The stock has a 50 day moving average of $25.59 and a 200-day moving average of $22.28.

HP (NYSE:HPQ – Get Free Report) last posted its earnings results on Wednesday, May 27th. The computer maker reported $0.86 EPS for the quarter, beating the consensus estimate of $0.72 by $0.14. The company had revenue of $14.41 billion during the quarter, compared to analyst estimates of $13.99 billion. HP had a negative return on equity of 581.36% and a net margin of 4.45%.The business’s revenue was up 9.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.71 earnings per share. HP has set its FY 2026 guidance at 2.900-3.100 EPS and its Q3 2026 guidance at 0.610-0.710 EPS. On average, sell-side analysts predict that HP Inc. will post 2.98 earnings per share for the current fiscal year. HP Announces Dividend The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 7th. Shareholders of record on Wednesday, September 9th will be paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 4.0%. The ex-dividend date is Wednesday, September 9th. HP’s dividend payout ratio (DPR) is presently 44.28%.

Analysts Set New Price Targets HPQ has been the subject of several recent analyst reports. Bank of America raised their target price on HP from $16.00 to $18.00 and gave the company an “underperform” rating in a research note on Thursday, May 28th. Morgan Stanley increased their price target on HP from $17.00 to $19.00 and gave the company an “underweight” rating in a report on Thursday, May 28th. Weiss Ratings upgraded HP from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, July 6th. The Goldman Sachs Group upped their target price on HP from $19.00 to $21.00 and gave the company a “sell” rating in a research report on Wednesday, August 12th. Finally, Wells Fargo & Company increased their target price on HP from $18.00 to $20.00 and gave the company an “underweight” rating in a research note on Thursday, May 28th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Hold rating and five have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Reduce” and a consensus price target of $23.50.

Get Our Latest Stock Analysis on HPQ

Insider Transactions at HP In other news, insider David P. Mcquarrie sold 21,048 shares of the business’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of $29.98, for a total transaction of $631,019.04. Following the completion of the transaction, the insider owned 39,580 shares of the company’s stock, valued at approximately $1,186,608.40. The trade was a 34.72% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 52,620 shares of company stock valued at $1,478,622 in the last quarter. Company insiders own 0.18% of the company’s stock.

HP Company Profile (Free Report)

HP Inc is an American multinational information technology company that designs, manufactures and sells personal computing devices, printers and related supplies and services. Its product portfolio spans consumer and commercial notebooks and desktops, workstations, displays and accessories, as well as an extensive line of printing hardware that includes home, office and production printers. HP also provides consumables such as ink and toner, managed print services, device deployment and lifecycle support, and software for device and print management.

Founded from the original Hewlett‑Packard Company, HP Inc became a separately traded public company in 2015 following a corporate split that created Hewlett Packard Enterprise to focus on enterprise hardware and services.

Further Reading Five stocks we like better than HP Bloom Energy’s AI Surge Meets a Valuation Reality Check Target Is Winning Shoppers Back—Can the Rally Reach $180? IonQ’s Space Contract Points to a New Frontier for Quantum Investors Is Apple’s AI Strategy Smarter Than Skeptics Think?

Receive News & Ratings for HP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HP and related companies with MarketBeat.com's FREE daily email newsletter.